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ABSTRACT
A new process for the production of a clinical (or controlled size)
dextrans was developed. This process is simpler, cheaper and more
economical than traditional methods. It involves the use of a mixed culture
fermentation with a dextranase producing strain (Lipomvces starkevi ATCC
74054) and a dextransucrase producing strain (Leuconostoc mesenteroides
ATCC 10830). The new process produced 84 % (w/w) of the theoretical yield
of clinical dextrans with an average polydispersity between 1.2 and 1.5. The
mechanism for clinical dextran formation is a competitive production of
acceptors from newly formed dextran molecules by dextranase. The
acceptors compete for the existing glucosyl portion of sucrose, resulting in
higher levels of small size dextran molecules. The maintenance of a proper
balance of dextransucrase to dextranase is essential for the functioning of
this process.

xiii

INTRODUCTION
Dextran is the collective term given to that group of bacterial
polysaccharides composed of chains of D-glucose units connected by a 1,6
linkages. Low molecular weight dextrans have their largest application in the
pharmaceutical industry. Various molecular weights and weight distributions
have been used as blood plasma extenders (dextran 70, average molecular
weight 70,000) and blood flow improvers (dextran 40, average molecular
weight 40,000). Dextran, circulating in the blood system is rapidly removed
by the kidneys if it is below an appropriate threshold size but slowly by
metabolic pathways if it is above a threshold molecular weight. Good
anticoagulant activity with low toxicity has been obtained with the dextran
derivative, dextran sulfate, of molecular weight 7,300 with 1.9 sulfate groups
per glucose residues (150). Dextran sulfate is also reported to inhibit some
virus infections. It can interfere with the initial adsorption of the virus to
susceptible cells (150, 176). Its action is molecular weight dependent. LMW
(low molecular weight) dextran sulfate specifically interacts with the major
envelope glycoprotein of HIV-1, inhibiting its ability to bind to CD 4 cells
(115, 121). In addition, cross-linked dextran, mercaptodextran, and irondextran have been used for various applications. The demand of dextran
derivatives has increased dramatically. The important factor for any dextran
derivative is its size.
Commercially, dextran is produced by whole culture fermentation.
Leuconostoc mesenteroides ATCC 10830 (F) is grown in a medium
containing sucrose along with other required nutrients. It produces a native
dextran with a molecular mass of about 5 x 108daltons. This is unsuitable
for blood plasma substitutes. Relatively low molecular weight dextrans (a
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few hundred to a million) are produced by controlled acid hydrolysis of
native dextran, followed by organic solvent fractionation. The process has
drawbacks. Since it is multi-step, the yields are relatively low due to losses
during acid hydrolysis and repeated fractionations and it has inherent high
viscosity because of the high molecular weight polymers. There have been
many studies on improving clinical dextran production with purified
dextransucrase (139, 148). A popular idea for making clinical dextran with
this enzyme has been to use maltose as an acceptor (148). However, this
process requires enzyme production and an enzyme purification step. An
enzymatic hydrolysis method for clinical dextran production has been
patented (129, 130). There is, however, no practical method to recover the
dextranase for re-utilization. Thus, for over 40 years, a whole culture
fermentation process, followed by de-polymerizations and fractionations has
been used for clinical dextran production.
This study reports on the production of a new, simpler, and industrially
practical method for producing clinical dextrans.

REVIEW OF LITERATURE

I. Dextran and its uses
Dextran is the collective term given to that group of bacterial
polysaccharides composed of chains of D-glucose units connected by a 1,6
linkages. Their structures (degree of branching), molecular weights and
other properties are specific to the organisms that produce them. Dextran is
synthesized only from sucrose. It is produced by bacteria of the family
Lactobacillaceae and specially the genera Lactobacillus (37, 43, 56, 66, 90,
100), Leuconostoc (74. 97, 146), and Streptococcus (36, 56, 57, 70, 175).
The commercial world market for this polymer is several billion kilograms a
year.
(1) Dextran as blood volume extenders and blood substitutes
Low molecular weight dextran (M.W. of 70,000 ± 25,000) is used as
an agent for restoring blood volume (63, 64, 151). Macromolecular and
colloidal materials have been shown for many years to act like natural blood
colloids (171). Early on, Swedish workers (63, 64) developed the use of
dextran for maintaining blood volume. Alpha 1,4 glucosidic bonds are
rapidly cleaved by human enzymes, whereas a 1,6 bonds are cleaved more
slowly. Obviously, polymers with a high proportion of a 1,4 bonds will rapidly
degrade to low molecular weight oligomers losing their properties as blood
volume expanders (153).
The possibility of dextran - hemoglobin solutions as a blood
substitute, serving at once the dual functions of plasma expension and
oxygen delivery, has been considered (145, 177). The removal of
erythrocyte stroma effectively detoxified such solutions (177). Stroma-free

3

4

hemoglobin can be sterilized by filtration, easily stored, and used in
transfusions without blood-group typing, its physiological properties have
been widely examined. However, due to its relatively small size, the
hemoglobin infused into the circulation is rapidly eliminated through the
kidneys and by other metabolic routes. To develop usable procedures that
can increase the effective size of the hemoglobin molecule and slow down
its disappearance from the circulation, a complex between soluble dextran
and human hemoglobin has been synthesized by alkylation or dialdehyde
method (177). Both soluble dextran - hemoglobin complexes could bind and
release oxygen reversibly. They found that the complex obtained by the
alkylation method was excreted by the kidneys and cleared from the
circulation more slowly than free hemoglobin.

(2) Dextran derivatives
Dextran esters and ethers have been produced having a diverse
range of properties. The properties depend upon the type and the degree of
substitution as well as the molecular size of the dextran. Dextran derivatives
are used in the photographic industry. Patents have been issued (29) on
improved film emulsions incorporating dextrans which use less silver without
any loss of fineness of grain.
a. Cross-linked dextrans - The most widely used dextran derivative is
the cross-linked dextran known as Sephadex™ (Pharmacia Fine Chemicals,
Ltd., Uppsala, Sweden). It is manufactured by the reaction of an alkaline
dextran solution with epichlorohydrin, producing cross-linked dextrans.
Cross-linked dextran matrices have a wide variety of uses including solid
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supports for affinity chromatography and bases for ion-exchange molecular
sieves.
b. Dextran sulfate - Sulfated esters of dextran are prepared by mixing
chlorosulfonic acid in pyridine at -10°C, raising the temperature to 60°C and
adding dry, finely powered dextran. Dextran sulfate is an anticoagulant with
properties similar to, although less effective than, heparin. Anticoagulant
activity increases sharply when sulfate substitution uses from 1.0 to 1.3
sulfate groups per glucose residue (150). High molecular weight dextran
sulfate is toxic because it precipitates fibrinogen producing embolisms (153).
Toxicity is greatly reduced in dextran sulfates with molecular weights of less
than 20,000. The approximate size of heparin is 17,000. Good anticoagulant
activity with low toxicity has been obtained from a dextran sulfates of 7,300
M.W. and 1.9 sulfate groups per glucose residue (150). Dextran sulfate also
interacts with p-lipoproteins and has found application in the determination
of serum cholesterol (150).
Dextran sulfate is reported to inhibit some virus infections. It can
interfere with the initial adsorption of the virus to susceptible cells (176).
LMW (low molecular weight) dextran sulfate (MW approximately 8,000
containing 17 to 20 % sulfate) specifically interacts with the major envelope
glycoprotein of HIV-1, inhibiting its ability to bind to CD 4 cells (115, 121).
HMW (high molecular weight) dextran sulfate 500 (MW 500,000) is
commonly used as a reticuloendotherial blocker. Lipopolysaccharide
induced tumour necrosis factor production in sera is enhanced when mice
are pretreated with dextran sulfate 500. The size of the dextran sulfate is
important (80). Dextran sulfate also has an affinity for the nucleic acids and
is a potent inhibitor of ribonuclease (144).
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c. Mercaptodextran - Mercaptodextran is synthesized by thiolating
dextran with N-acetyl homocysteine thiolactone. The thiol groups of
mercaptodextran are stable toward autooxidation. Mercaptodextran has a
higher affinity for heavy metal ions, specifically, mercuric, and cupuric ions
than other thiols or chelating agents. This affinity for heavy metal ions,
combined with low toxicity make dextran sulfate useful in treating acute,
heavy metal poisoning and in the environmental clean up of heavy-metal
contamination (76).
d. Iron-dextran - when LMW dextran is treated with water-soluble,
weakly electrolytic Iron (III) salts at 40 ° - 115 °C at pH 11.5 is produced a
complex containing from 5 to 30 % (by weight) of iron (27). These complexes
are used in the treatment of iron deficiency anemia in both human and
veterinary medicines. Iron dextran contain 20 % (w/v) Fe (4).
e. Other dextrans - Many other dextran derivatives such as
carbonates, triacetates, phosphates, nitrates, benzyl and hydroxyalkyi ethers
have been synthesized. Their uses range from tableting and encapsulating
agents (9) to emulsifying and thickening agents (181), high viscosity gums
(182), explosives (118, 128), soil conditioners (131, 191), well drilling (136),
etc.

II. Dextransucrase
Dextransucrase (sucrose 1, 6-a-D-glucan 6-a-glucosyltranferase, EC
2.4.1.5) is an extracellular enzyme secreted by species of Leuconostoc and
Streptococcus. It polymerizes the glucosyl moieties of sucrose to form
dextran (119). The reaction is represented by the following equation;
nCi2H220ii —> (C6HioC>5)n + nCeH^Oe.
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L. mesenteroides dextransucrase - Dextransucrase from
mesenteroides 10830 (B-512) F is an industrially important enzyme due to
its ability to synthesize dextran. Studies of its mechanism have added both
theoretical and practical aspects to understanding the mechanisms of
glucan synthesis and glucosyl transfer reactions with acceptors. This
enzyme constructs dextrans, containing 95 % a 1,6 bonds and 5 % a 1,3
bonds in the form of branches using sucrose as an a-D-glucosyl donor for
the synthesis of D-glucans.
(1) Dextransucrase production
Many researchers have proposed multi-step processes using purified
dextransucrase to produce clinical dextrans. The hydrolysis of sucrose
provides the energy required for the condensation of D-glucopyranosyl
units, allowing in vitro dextran synthesis. Dextransucrase produced by
Leuconostoc sp. on low level of sucrose. The inoculation rate is generally 1
or 2 % (v/v), large inocula accelerate the rate of fermentation but decrease
the yields of dextransucrase (184). High sucrose levels induce higher
enzyme production. However, even with 3 to 5 % sucrose, the culture
produces so much dextran as to render the cell removal difficult. Two
percent sucrose is accepted as the optimal level for the production of
dextransucrase by Leuconostoc sp. At this concentration of sucrose dextran
formation is little, suggesting that the sucrose is being used completely as an
energy

source (126). Dextransucrase is not produced

when

mesenteroides is grown on glucose or maltose (106).
Monsan and Lopez (122) and Schneider et al. (162) reported
dextransucrase activities, in broth, of 178 DSU/ml and 300 DSU/ml,
respectively. One dextransucrase unit (DSU) is the amount of enzyme which
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will convert 1 mg sucrose to dextran in 1 hr liberating 0.52 mg fructose at a
pH 5.2 and a temperature of 25 °C. Variation of sugar type, i.e. maltose,
glucose and fructose instead of sucrose (24, 126), and sucrose
concentrations (4, 184) to increase dextransucrase yields have been
attempted. Fed-batch fermentation under pH (5, 25) and temperature control
with optimized aeration (105, 162) have had limited success.
Using continuous culture Lawford et al. (106) produced approximately
0.75 lU/ml dextransucrase with a dilution rate of 0.53 hr1 and Paul (139)
obtained 3.4 U/ml/hr with a dilution rate of 0.4 hr1. One unit (U) of
dextranase was defined as the amount of enzyme which liberates 1 ^mole of
isomaltose equivalents. Pennell and Barker (142) produced approximately
5 U/ml/hr of dextransucrase in an unaerated continuous fermentations. The
effect of yeast extract quality, sucrose concentration and agitation rate in
continuous culture have been studied for their effect on dextransucrase
production. Under

sucrose limited growth, Lawford et al. (106) found

dextransucrase activity in the supernatant increases with dilution rate only
after a critical concentration of inducer (sucrose) in the chemostat is
reached. Paul et al. (138) obtained 3 fold higher enzyme productivity with
continuous culture than with fed-batch culture.

(2) Purification and characterization of dextransucrase
a. L. mesenteroides

dextransucrase

- L. mesenteroides

dextransucrase is purified from the culture broth of sucrose fermentation. It is
purified by a sequence including dextranase treatment, DEAE-cellulose
chromatography, affinity chromatography on Sephadex G-200, and
chromatography on DEAE-Tris-acyl M (119). It has a pH optimum of 5.0 - 5.5,
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and a Km of 12 - 16 mM. Robyt and Walseth (159) found that B-512F
dextransucrase was a mannoglycoprotein. Enzyme preparation composed
of two major proteins with molecular weights of 158,000 and 177,000. The
177,000 form predominates in fresh preparations, whereas the 158,000 form
increases at the expense of the 177,000 form during storage. A B-512F
mutant (B-512FM) produces a single dextransucrase of molecular weight
158,000 (52). Kobayashi

et al. (86) reported different sizes

for

dextransucrase. They obtained relatively small amounts of apparently
homogenous dextransucrase from B-512F that had a molecular weight of
64,000. This is the lowest molecular weight reported for this dextransucrase.
Their preparation had very low dextran synthesizing activity but a high
sucrose hydrolyzing activity. Kobayashi and Matsuda (87) reported the
presence of multiple forms of the extracellular dextransucrase from B-512F.
Dextransucrase aggregates were a mixture of two, i.e., oligomers of a 65K
protomer and their charge isomers. Since the highly aggregated form
showed a higher activity for dextran synthesis than the dissociated forms,
they suggested that endogenous dextran acts as a source of primer that
stabilizes the enzyme molecule. They also suggested that the occurrence of
oligomeric forms of the enzyme might play an important role in the control of
dextran synthesis in vivo.
Paul reported the purification of a dextransucrase using phase
partition (140). The molecular weight of the monomeric active enzyme was
estimated to be 65,000. The molecular weights of the aggregated enzymes
were 130,000 and 195,000. The isoelectric point of the dextran free protein
was 4.0. Enzyme activity was stimulated by dextrans addition and the Km
value decreased with increasing dextran concentration (85).

Dextransucrase will polymerize the D-glucosyl groups from a-Dglucopyranosyl a-L-sorbofuranoside (114), 0-p-D-galactopyranosyl-1,4-pD-fructofuranosyl a -D-glucopyranoside (lactosucrose) (2), p-nitrophenyl a D-glucopyranoside (3), and a-D-glucopyranosyl fluoride (4). These
substrates differ from sucrose only in the leaving group. All have an a-Dglucosidic linkages of energy similar to, or higher than, that of sucrose (17).
The a-glucosyl moiety, which is important for binding and subsequent
polymerization, is unchanged. Kobayashi et al. (89) studied the substrate
binding sites of Leuconostoc dextransucrase by inhibition kinetics. They
proposed a mechanism, in which the donor (sucrose) and acceptor (dextran)
bind to distinct, separate sites on the enzyme. They reported that D-fructose
and maltose were inhibitors of dextransucrase. Miller and Robyt (120), using
radiation inactivation to measure the minimal enzyme unit required for
activity, reported that L. mesenteroides B-512F dextransucrase has two
nucleophilic sites. They are located on the same peptide, rather than on
different subunits in a dimer. Peptide association is not required for dextran
synthesis. Fu and Robyt (50) proposed that two imidazolium groups of
histidine are in the active site. They donate protons to the leaving, Dfructosyl moieties. The resulting imidazole groups facilitate the formation of a
1,6 glycosidic linkages by abstracting protons from the C6-OH, becoming
reprotonated for the next series of reactions. Using a series of a-1fluorosugars Grier and Mayer changed the configurations of

specific

hydroxyl groups of the glucosyl moiety to examine substrate specificity (61).
Analogs of a-D-glucopyranosyl fluoride were found to be inhibitors of
dextransucrase but did not act as glucosyl donors. Epimerizations at C2, C3,
and C4 produced competitive inhibitors. Four and 6-deoxy-glucopyranosyl
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fluoride were competitive inhibitors. It is likely that hydroxyl groups are
important for the binding of substrate to the active site via hydrogen-bond
formation. New substrates may be found for dextransucrase if the hydroxyls
on the glucose ring can be replaced with other groups that can participate in
hydrogen bonding. Michiels (117) tested a-D-glucopyranosyl fluoride at
positions 2, 3, or 5 as substrates and inhibitors of dextransucrase. They
found C2 and C3 hydroxyl groups are important for the proper binding of aD-glucopyranosyl fluoride to the dextransucrase active site and that the C3hydroxyl probably acts as a hydrogen-bond donor.
b. Streptococcus dextransucrase - Dextransucrase produced by fL
sanguis is a constitutive extracellular enzyme. It can be purified from the
culture fluids of late log or early stationary phase cells grown on glucose or
other simple carbon sources. The organism also produces a protease that
cleaves the proto dextransucrase, producing a fully active form with a
molecular weight of 156,000. After proteolysis, the aggregate and oligomeric
forms of the enzymes are hybrids of the proto and proteolyzed monomers
(59). This enzyme has a pH optimum between 6.0 and 6.5, and an
isoelectric point of 5.15. The Km for sucrose in the presence and absence of
acceptors (dextran T-10) is 5.09 and 0.93 mM, respectively. The
glucopyranosyl configuration is necessary for donor activity (61, 79).
Acceptor substrate specificity is extremely broad. It ranges from simple
alcohols, such as ethanol, to glucose oligosaccharides and dextran. While
dextran is the probably the best acceptor for this enzyme, the
oligosaccharides are the most widely investigated (117). Fructose also
serves as an acceptor. However, it generates two types of products. Over a
short reaction time (10 - 15 seconds) it forms sucrose by an isotope

exchange reaction (112) and over 3 hrs reaction time (117) leucrose (5-O-aD-glucopyranosyl-D-fructopyranose) and maltulose (4-O-a-glucosyl-Dfructose) are the major products. The active site numbers and branch
formation mechanisms are similar to L. mesenteroides dextransucrase (31,
157).
Some Streptococci produce soluble polymers whereas others yield
insoluble ones. The terms GTF (S) and GTF (I) have been used to designate
the enzymes responsible for the formation of soluble and insoluble polymers
(28). Since solubility is related to the proportion of a 1,6 bonds, those
enzymes that form soluble polysaccharides are more specifically designated
as dextransucrases. The reactions catalyzed by glucosyltransferases may
play an important role in the formation of dental caries. Four kinds of
glucosyltransferases (GTase) have been purified from S. mutans serotype g.
(67, 68, 116, 165, 195, 197). They are two primer independent GTase's and
two primer dependent GTase's. One of the primer dependent GTase's
produces highly branched, water soluble glucans (165) and the other is
water insoluble glucans (67, 116). The two primer independent GTases
produce water soluble glucans and supply the primers for both primer
dependent GTase's (68, 116). One of the primer independent GTase's is a
donor for the branching enzyme (195, 197). Kobs (91) reported the presence
in S. sanguis dextransucrase of a catalytic domain that contains two nonequivalent sites. One site confers the ability to bind to acceptor molecules
such as dextran, with high affinity. The other site is responsible for the
formation of the glucosyl-enzyme intermediate by sucrose hydrolysis. They
suggested that two acceptors binding sites exist on dextransucrase (92).

c. Dextransucrase properties - Willemot et al. (190) observed that the
dextran in the dextran-enzyme complex has activating and stabilizing effects
on activity. They suggested that a local concentration of dextran in the
microenvironment of the enzyme is important. Kobayashi and coworkers
(86) reported that the addition of exogenous dextran stimulated the sucrase
activity (sucrose cleavage) 1.3 fold, and transferase activity (dextran
synthesis) 9.6 fold. Kobayashi et al. (88) reported that, in contrast to dextran,
low-molecular weight sugars did not stimulate the transferase. In fact,
glucose, fructose and maltose inhibited transferase activity. D-Fructose and
maltose were competitive inhibitors of the transferase reaction with Ki value
of 44.8 mM and 5.4 mM, respectively. Maltose and isomaltose are
competitive inhibitors of Streptococcus GTF-S. However, nigerose had no
effect on GTF-S activity. The Ki values for these inhibitors are 0.8, 2.5, and
15 mM, respectively. Kobayashi and coworkers reported that 0.075 %
fructose or 0.15 % maltose in sucrose solutions inhibited dextransucrase
activity (89).
Dextransucrase is inactivated by EDTA and the enzyme activity can
be recovered by the addition of alkaline earth metal ions (72). It is probable
that the enzyme occurs as a calcium-enzyme. Dextransucrase thermal and
pH stability increase upon addition of 0.1 mM Ca** ion (72). Optimal pH for
dextransucrase production is ranged from 6.5 to 7.0 and the optimal pH for
dextransucrase activity is 5.0 to 5.2. Dextransucrase activity is most stable in
the same pH's. Over pH 5.8, dextransucrase activity decreased to less than
25 % of the original activity after 1 hour. Upon the addition of Ca4-* ion, the
dextransucrase is stable over a pH range of 5.0 to 6.0 (5).

(3) Mechanism of action
a. Dextransucrase reaction mechanism - The mode of action of
dextransucrase has been the subject of argument for 40 years. When
dextransucrase was discovered (1941), Cori and Cori (30) were working on
the synthesis of glycogen. This polysaccharide molecule is built by the
addition of glucose, from a-glucose-1 phosphate, to the

growing chain's

non-reducing end. Similar mechanisms were postulated for dextran
formation, until it was found that phosphorylated sugars were not involved in
dextran synthesis.
Two mechanisms have since been proposed for the dextransucrase
reaction. Either the enzyme remains in combination with the growing
polymer chain (170), therefore a single chain mechanism operates, or the
enzyme separates from the growing chain. The single chain mechanism was
supported by those workers who failed to detect oligosaccharides or low
molecular weight dextran (5) in pure cultures of L. mesenteroides. There
were also controversies about the start of polymerization and the need for
primers. Germain et al. (54) reported that S. mutans dextransucrase activity
from glucose grown cultures was partially primer dependent. They reported
that the non-reducing ends of dextran were substrates and served as the
necessary primers for new dextran synthesis (55). They hypothesized that
equal concentrations of dextrans of different molecular sizes would have
equal concentrations of non-reducing ends and different concentrations of
reducing ends. Depending on the site for priming, the non-reducing end or
reducing end, the activation would be identical or different with the dextran
size. They found that activation was identical for different sized dextrans. The
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activation was also identical for a dextran that had been modified at the
reducing end. Germain's explanation is, however, at odds with Robyts'.
Ebert and Schenk (46), and Robyt and Corrigan (154) proposed a
mechanism for growth from the reducing end. Robyt and Corrigan used
dextran modified at the non-reducing ends and found dextransucrase
activation. Because the non-reducing ends of the modified dextrans were
not available for reaction, they concluded reducing end growth. To study the
primer

requirement Robyt

and Walseth (158)

prepared

charged

dextransucrase by incubating the enzyme with sucrose. They separated the
charged enzyme from the resulting fructose and un-reacted sucrose on BioGel P-6 (BGP). This enzyme was then incubated with
fructose, or

14 C-maltose

14 C-glucose,

14 C-

all labeled at the reducing end. They found each of

the labeled acceptors produced two labeled products. Reduction and acidhydrolysis of the labeled products showed that all three of the acceptors
were incorporated into the products at the reducing end. The reaction
occurred in the absence of sucrose. They concluded that primers were not
necessary to initiate polymer growth (Figure 1). The termination step is not
completely understood, but evidence suggests that dextransucrase bound
saccharides are released slowly (39, 112). Ebert and Schenk (46), and
Robyt (152) tried to explain chain termination using insertion theory, that is
the bond between the enzyme and the growing chain is broken in such a
way that it cannot be reformed. This breakage occurs by interference of an
acceptor. Their mechanism for dextran branch formation is also explained by
this insertion mechanism (152). The C3-OH of an acceptor dextran makes a
nucleophilic attack onto the C1 of the reducing end of the dextranosyl- or
glucosyl-dextransucrase complex. It releases them from the active site and
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Mechanisms proposed for the synthesis of dextran by
Leuconostoc mesenteroides ATCC 10830F dextransucrase (A)
and the acceptor reactions (B) (150).
(A) Xi and X2 represent nucleophiles at the active site;
represents sucrose;open circle is glucose; open triangle is
fructose; O - 0 indicates glucose residues joined by a-1, 6glucosidic linkages.
(B) (a) is the reaction of isomaltose displacing the glucosyl and
dextranosyl groups from the enzyme to give respectively
isomaltose and dextran terminated at the reducing end by
isomaltose; (b) is the reaction with acceptor-dextran to give a
single glucose unit; open circle or closed circle is glucose; —
is an a-1, 6- glucosidic linkage and arrow is an a-1, 3 branch
linkage. The solid symbols represent 14C-labeled units.
Slashed closed circle indicated reducing end glucosyl group of
acceptor.

forms a 1,3 branch linkages with the exogenous dextran. They suggest that
in the biosynthesis of branched dextran, a separate branching enzyme is not
required. The synthesis of branch linkages can occur by acceptor reaction.
However, the synthesis of different types of branches, the 1-2, 1-3, and 1-4
glucosidic linkages, which are occasionally detected in the same dextran
molecule, cannot be explained by this mechanism.
b. Acceptors - When acceptors, other than sucrose, are present in
reaction mixtures, D-glucopyranosyl residues can be transferred to them (46,
78, 158, 173). If the acceptor is a low molecular weight sugar, a
monosaccharide, disaccharide, or trisaccharide, the product is a low
molecular weight oligosaccharide. The molecular weight increases only by a
D-glucosyl group (155). Maltose is the most efficient acceptor, followed in
order by isomaltose and nigerose. High

degree

of

polymerized

oligosaccharides (d.p. 8 to 13) are found in all reaction digests. This is
evidence against acceptors as primers of dextran. Rather than acting as
primers they terminate polymerization. Some acceptor products can also act
as acceptors resulting in a series of homologous acceptor products.

D-

fructopyranose is a poor acceptor (or non acceptor), whereas Dglucopyranoside, which is composed of an equilibrium mixture of a- and panomers in a ratio of 1: 2 is an effective acceptor (155). Because of their
structural and conformational differences, D-galactose and D-mannose are
very poor acceptors. Fu and Robyt reported on the relative effectiveness of
various acceptor analogs (51). In decreasing order of effectiveness they are
2-deoxy, the 2-epimer, 3-deoxy, the 3-epimer, the 4-epimer, and 4-deoxy of
a-methyl-D-glucopyranoside. The hydroxyl group at C2 is not as important
for acceptor binding as the C3 and C4 hydroxyl groups. The C4 hydroxyl

group determines the binding orientation of the a-methyl-D-glucopyranoside
ring (51). Reactions in which glycosyl groups are transferred from one
saccharide donor to identical, or similar saccharide acceptors, are known as
disproportionation reactions. For example, two maltose

units become

glucose and maltotriose. This reaction has been observed for cellulase (81),
amylase (49), glucoamylase (84), transglucosylase (141), glucodextranase
(83) and isomaltodextranase (161). This reaction is also seen with
dextransucrase

(16,

183).

The

formation

of

enzyme-D-glucosyl

intermediates from the substrate and the subsequent displacement of the Dglucosyl group by an acceptor produce disproportionation of the substrate
(16). The transfer of D-glucosyl groups from one dextran chain to another
can form branch dextrans.
Tanriseven and Robyt (178) proposed that the acceptor binding site is
between the two glucosyl (or dextranosyl) groups. The binding of the
acceptor to its binding site blocks the insertion of the glucosyl residue into
the growing dextran chain. It causes the inhibition of dextran synthesis and
the diversion of the glucosyl residue onto on acceptor. Similarly, the
acceptor can react with the dextranosyl chain releasing it from the active site
and terminating polymerization. They proposed that the acceptor binding
site has a minimum of two glucosyl subsites. Maltose, which has two
glucosyl moieties, is the most effective acceptor (96).
L. mesenteroides NRRL B-742 produces two extracellular dextran, L
fraction, which consists of an a-D-(1,6) backbone with a-D-(1,4) branch
points, and an S fraction, which consists of an a-D-(1,6) backbone with «-D(1,3) branch points. Cote and Robyt (33) reported that any change in
reaction that affects the rate of acceptor reaction relative to chain elongation

affects the degree of branching in the S fraction. They also found that
glucansucrase was capable of modifying the L fraction, by transferring Dglucosyl groups to OH-3 of D-glucosyl residues. Dextran synthesis
conditions play an important role in structure determination. Calcium is
required by B-512F dextransucrase and may play a role in branch formation
by dextransucrases (106, 159). Tsumuraya et al. (186) found the content of
a-1,6 glucosidic bonds in dextran increased with increased purity of
dextransucrase. Calcium ion (+2) was to be a powerful branching factor at
concentrations above 0.03 M. Magnesium ion (+2), Mn2+ ion and Fe2+ ion
also showed branching activity above concentrations of 0.03 M, 0.1 M and
0.0005 M, respectively. The mechanism how metal ions act as branching
factors is not understood. However, it is possible that they alter the
conformation of the active site so as to preferentially synthesize non a-1,6
bonds. More dextran with a lower content of a-1,6 bonds were formed at
between pH's 5.5 and 6.0 (about 85 % a-1,6 linkage) than at pH's between
4.3 and 5.0 (about 90 to 95 % a-1,6 linkage). These pH's may induce active
site conformation changes. Both pH and divalent metal concentrations
influence the degree of branching in dextrans produced by the
dextransucrase from L. mesenteroides IAM 1046 (186).

III. Dextran production
(1) Batch culture
Commercially, dextran is produced from the fermentation of sucrose
bv L. mesenteroides. The organism is grown in a medium containing high
concentrations of sucrose (15 %) along with the other required nutrients,
salts, vitamins and minerals. The typical commercial growth media
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composition is ; Yeast Extract 5 (g / L), Peptone (trace amount, detailed
information is not available), KH2PO4, 5 g / L, pH between 7.0 and 4.8, 15 %
sucrose (Dr. Patel, Personal communication, Chemdex Inc., FL). Sometimes
0.002% CaC^isalso added (138). The cells secrete dextransucrase which
converts sucrose to dextran. Batch processes terminate when all of the
sucrose has been utilized and the medium pH has dropped to 4.8 - 5.0.
Although all the sucrose is consumed, the final yield of dextran is only about
52 % of the theoretical yield. Alsop (5) reported that lower starting sucrose
concentrations produced higher yields, reducing sucrose costs. However,
net production (and the concentration) of dextran was lower, reducing plant
productivity and substantially increasing downstream processing costs.
Alsop concluded that the most economic sucrose concentration lay between
170 and 180 g/L for a batch fermentation. The pH has a significant effect on
dextransucrase production. Otts and Day (134) reported that dextransucrase
export in L. mesenteroides is dependent on the total proton motive force
rather than solely on membrane potential (A^orApH. Dextransucrase
export is more susceptible to dissipators of membrane potential at higher
pH's (6.4) and more susceptible to dissipators of ApH at lower pH's (5.5).
The optimum pH for growth of Leuconostoc is between 6.0 and 7.0, where
the mean doubling time is 31 ±2 min. The doubling time increases when the
culture pH was outside this range. At pH 5.0 the mean doubling time
increases to 60 min (135). A decrease in the external pH has little effect on
the rate of dextransucrase secretion. Cells maintain a constant proton motive
force of -130 mV when grown within

a pH range of 5.8 to 7.0 (135). Ap

decreases until it reaches a value of -112 mV at pH 5.3. The contribution of ZApH to Ap increased from 0 mV at pH 7.0 to -50 mV at pH 5.3 (135). This

implies that dextransucrase secretion in L. mesenteroides is dependent on
the presence of a proton gradient across the cytoplasmic membrane.
Tsuchiya et al. (184) carried out controlled pH, batch fermentations between
pH 6.1 and 6.9 and demonstrated that maximum enzyme concentration was
reached at pH 6.7. However, the maximum production rate was observed at
pH 6.1. At pH 6.0 and below, the enzyme is stable, retaining 100 % of activity
for five hours at pH 5.4 (101). Above pH 6.0, the enzyme is far less stable,
retaining only 10 % of its original activity at pH 6.6 (101).
In commercial, semi-continuous processes (14) of a preculture of L
mesenteroides is used as an inoculum at a rate of 10-20 % (v/v) for a
nutrient solution containing a large amount of sucrose (15 % final sucrose
concentration). This may be repeated ten times without a change in dextran
quality. Impure dextran, which is nevertheless suitable for technical use, can
be obtained using final molasses as a substrate instead of sucrose (15, 77).

(2) Cell free fermentation
Hehre (69) was the first to synthesize dextran using L. mesenteroides
cell-free extracts. Since then, different media compositions and fermentation
conditions have been applied to improve the yield of dextransucrase (88,
105). The enzyme is produced separately from dextran and then transferred
to a sucrose. The cells are removed and the filtrate can either be used
directly to synthesis dextran or can be concentrated by ethanol precipitation
as a dextransucrase-dextran complex. This can be stored for subsequent
use (73). Enzymatic synthesis of dextran has advantages over synthesis by
growing cultures that include a clearer product, better control and the
production of a more uniform dextran. For dextran production, the purified
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enzyme (500 units/ liters of sucrose solution) is added to 300 mM sucrose.
One enzyme unit is the amount necessary to incorporate one micromole of
glucose from sucrose into dextran in 1 min under specified pH and
temperature. The yield after 10 hours (one conversion period) is about 45 g
of dextran/ liter. Yields depend on the amount of enzyme added to the digest
and the amount of sucrose in the digest (153). This process has never been
commercialized because of the high cost of producing and purifying
dextransucrase.

(3) Immobilization of dextransucrase
There have been numerous attempts to immobilize dextransucrase in
order to reduce enzyme costs (122, 123, 137, 156). Generally there are
large losses of activity upon immobilization (156) and alterations in the
reaction kinetics of the enzyme(123). Affinity immobilized dextransucrase
(91, 111) has been used. Abdel-Halim et al. reported increased production
of both dextransucrase and dextran using L. mesenteroides immobilized in
calcium alginate beads. Because alginate beads lose mechanical strength
in the presence of high concentrations of Na+ or K+ions, calcium alginate
was layered on porous Celite R630 particles (1).
Monsan et al. found (123) the specific activity of immobilized
dextransucrase was elevated in the presence of maltose. The Vmax values
decreased when the larger acceptors, such as maltose, panose, D.P.4,
D.P.5, and D.P.6 were used. They immobilized their dextransucrase on
porous silica activated by glutaraldehyde. They found, without acceptors in
the reaction medium, dextran is released only after it attains a very high
molecular weight. It then causes plugging of the supports pores. The
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resulting increase in viscosity induces high resistance to intraparticular mass
transfer, and in particular, fructose diffusion to the exterior of the support.
Using maltose as an acceptor, with a sucrose to maltose ratio of 2, they
could obtain oligodextrans of less than 20,000 M.W. To synthesize clinical
dextran (M.W. 70,000) this method would require at least two consecutive
synthesis steps.

IV. Commercial processes for producing low molecular weight dextrans
The impetus for commercial production of dextran was the production
of

"plasma volume expander". Native dextran, with a molecular mass of

about 5 x 108 daltons is unsuitable as a blood-plasma substitute. The
optimum size for blood-plasma dextran, so called clinical dextran, is 50,000 100,000 daltons (62). Clinical dextran requires a product having a weight average molecular weight of 75,000 ± 25,000, determined by the light
scattering method. The distribution of molecular sizes is further specified by
stating that the 5 to 10 % of the sample having the lowest molecular weight
shall not have an average molecular weight below 25,000 and the 5 to 10 %
of the sample having the highest molecular weight shall not have an
average molecular weight above 200,000. This relatively low molecular
weight range dextran is produced by controlled acid hydrolysis of native
dextran, followed by organic solvent fractionation (18, 66). L. mesenteroides
B-512 is mass cultured as for ordinary dextran production. The cells are
removed and the dextran is precipitated with organic solvents. The
precipitated dextran is re-dissolved and hydrolyzed with hydrochloric acid at
100 - 105° C. The course of the hydrolysis is followed by viscosity change

until an optimum end point is reached. The hydrolysis is stopped by cooling
and neutralizing the acid.
The solution, after hydrolysis, contains dextrans with molecular
weights ranging from a few hundred to one million. The mixture is
fractionally precipitated with organic solvents to produce clinical dextran.
Repeated fractionation produces dextran with the required narrow molecular
weight range. This solution is then deionized in mixed - bed deionizing
columns and the volume is reduced by evaporation. Spraying drying
produces a free - flowing, white powder with an average size of 40 urn and
an average molecular weight of 75,000 (18).
(1) Dextran depolymerization
a. Acid hydrolysis - Generally, a 5 %(w/v) aqueous solution of NRRL
B-512 dextran is heated to the hydrolysis temperature. The amount of acid
required to give the desired pH is then added as quickly as possible with
rapid stirring. The hydrolysis is timed from the moment all of the acid is
introduced. The relative viscosity of the solution, measured at 25°C, is the
criterion for judging the extent of hydrolysis. The relative viscosity decreases
rapidly at first. Typical curves illustrating the change in viscosity with time
under different conditions of temperature and acidity have been published
(192). A higher temperature and a lower pH can shorten the hydrolysis time
to produce clinical dextran. It takes two hours to complete the hydrolysis to
clinical dextran at 99°C and at pH 1.6. The hydrolysis is stopped by rapid
cooling of the hydrolyzate and simultaneous neutralization with slightly less
than the required quantity of sodium hydroxide. The pH after neutralization
of the solution with dilute alkali, at room temperature, is 6.5 to 7.0. Acidhydrolysis is favored over enzymatic hydrolysis because the reaction can be
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carried out in conventional equipment, and can be readily controlled. The
effect of pH, temperature, time of hydrolysis, acid type, dextran
concentrations, hydrolysis extent and variation of fractionation condition, on
the course of dextran degradation and on product obtained have all been
studied (192). Both, hydrochloric acid and sulfuric acid produce equivalent
product. Differences that are found are attributable to the differing amounts
and types of salts present. This can be compensated for a slight shifting of
alcohol limits on precipitation. The choice of acid in dextran hydrolysis is
governed by whether or not the nonvolatility and lessened corrosiveness of
sulfuric acid are considered important and whether the lesser solubility of
sodium sulfate in aqueous alcohol and its tendency to precipitate with the
dextran fraction outweigh these advantages.
b. Thermal depolymerization - When powdered macromolecular
dextran, dried from solution at pH 7.0, is heated in a vacuum at 100°C,
depolymerization occurs. This is indicated by a fall in the viscosity of the
aqueous solution. Further heating at higher temperatures (e.g., 150°C)
results in discoloration, loss of water and a crisp friable product that contains
only a small amount of water-soluble material. Under conditions of oxygen
exclusion, similar heat treatment at neutrality and in a vacuum produces
water-soluble products of low viscosity. Thermal cleavage appears to take
place under more conveniently controlled conditions in aqueous phase at
pH 7.0. The heating of dextran solutions in the presence of reducing agents,
at different pH's resulted in viscosities indicative of depolymerization. Under
reducing conditions, at neutrality, depolymerization proceeds smoothly and
results in the formation of colorless, highly soluble polysaccharides which
precipitate with the usual organic solvents. The viscosities required for
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clinical dextrans can be reached in 24 hours at temperatures between 160
and 170 °C (169). The mechanism of this degradation is different from that of
acid hydrolysis. The thermally degraded materials have higher 1,6 to non1,6 linkage ratios than the original material and have higher optical
rotations, approaching that of un-degraded dextrans (194). The branched
nature of heat-degraded dextran is higher than would have been expected
from the observed viscosities (163).
c. Depolymerization of dextran by ultrasonics - The depolymerization
of branched dextrans can be brought about by ultrasonic treatment of these
macromolecules in aqueous solutions (104). The ultrasonically produced
fragments, when examined by fractional precipitation methods, show a
greater homogeneity than the more random acid hydrolytic products (104).
Unlike with acid degradation, reducing material is not produced. This
depolymerization is similar to the alkaline depolymerization of dextran
described by Stacey and Youd (170). They suggested that the mechanism is
a disrupting of the dextran hydrogen bonds. Ultrasonic dextran was free from
carboxyl groups (168). Reducing oligosaccharides were not produced and
generally the molecular size of particles was spread over a much narrower
range than with acid hydrolysis. Ultrasonically depolymerized dextran was
neutral in aqueous solutions. They did not cause anaphylaxis on injection
into guinea pigs and were non-toxic and non immunogenic in rabbits (13).
d. Enzymatic hydrolysis of dextran - Dextran hydrolyzed by endo
dextranases produce only a small amount of reducing sugar during the time
required for the production of molecular weight 75,000 dextran (26). Filtrates
from Aspergillus sp. cultures on dextran containing media are highly active
in splitting dextran. Eight liters of a 20 % sucrose media was fermented with

L. mesenteroides 683, producing 6.1 % (w/v, or 63.5 % of theoretical)
dextran, 1 % (v/v) of the mold filtrate was added and enzymatic action
allowed to proceed for 40 min. The action of the enzyme was stopped by
adding alkali to pH 9. By the alcohol fractionation 400 g of product with an
average molecular weight of 71,000 was obtained (or 52.8 % of theoretical
yield). The advantage of this method is that enzyme solutions can be
allowed to act directly on fermented culture media containing dextran. This
eliminates a preliminary precipitation of the polysaccharide with alcohol

(26).
(2) Dextran fractionation
Dextran hydrolyzates are fractionated by the graded addition of
methanol, ethanol or isopropanol. A standard fractionation scheme is
illustrated diagrammatically in Figure 2. The importance of fractionation
cannot be over-emphasized. Highly fractionated dextran is used as clinical
dextran (19), and for hydrodextran (200), dextran sulfate production (150),
and for various drugs storage forms (180, 199). A 2 % (v/v) error in the
alcohol content during fractionation seriously affects the molecular
distribution and, in turn, the yields of desired dextran. The alcohol can be
removed by boiling the dextran syrup. However, complete removal by this
method is neither practical nor necessary. The presence of alcohol, up to 16
% by volume, in the dextran has relatively little effect on the apparent weight
average (58).
a. Alcohol fractionation - For equivalent concentrations, methanol
does not precipitate clinical dextrans as effectively as does 95 % ethanol.
For example, a 6 % (v/v) ethanol difference yields 26 to 41 % (w/w) of twice
refractionated clinical dextran, whereas, a 6 %

(v/v) methanol difference
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produced only 16 % (w/w). Comparisons have been made between
methanol, ethanol, and isopropanol as precipitants. The precipitation
efficiency of these solvents is methanol <ethanol cisopropanol. The
sensitivity of the precipitation to alcohol concentration is in the reverse order.
Precipitation of 95 % (w/w) of dextran requires a 42.8 % (v/v) methanol, and
39.4 and 39.1 % (v/v) absolute ethanol and iso-propanol, respectively.
Generally, relative to methanol the precipitating powers of these alcohols
does not vary greatly over the entire range for precipitation. The precipitation
power is related to the molecular weight of the hydrocarbon portion of the
alcohol and the dielectric constant of the precipitant. The conditions for
fractionation and hydrolysis for B-512 (F) dextran cannot necessarily be
applied to other dextrans (193). Because fractionation procedures are
imperfect, repeated fractionations are necessary to produce dextrans having
a narrow enough molecular weight range for clinical use.
b. Other methods - Gel fractionation of low molecular weight dextrans
(M.W. less than 40,000) has been investigated (60). For this molecular
weight range fractionation by conventional means, precipitation and
extraction, often fail (75). Using "Sephadex" (Pharmacia Co.) gel, which has
water region (Wr) of 7.6 and 100 - 200 mesh, mixture of different size
dextrans can be separated (M.W. of 3,400 and 41,000). Both of the polymer
fractionation techniques currently in wide use, fractional precipitation and
gel permeation chromatography, require skilled operators (10). Fractionation
of dextran by ultrafiltration, using membranes with sharp molecular weight
cutoffs, has also been tried (10). Three different techniques have been
employed. They are batch ultrafiltration, using progressively more retentive
membranes, continuous ultrafiltration using three similar membranes in
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series and variable pressure ultrafiltration using a single membrane and
varying the applied pressure (from 5 to 40 psi). Different intrinsic viscosity
material has been found for each fractionation.

V. Dextranases
Dextranases (E.C. 3.2.1.11) are enzymes that cleave the a-(1-6)-Dglucopyranosyl linkages in dextrans. They do not cleave either the a 1-4 or
1-3 linkages. The enzyme is classified catalytically as either exo-acting or
endo-acting. Both classes exhibit pseudo-first-order kinetics. Some
dextranases also can carry out transglycosylation reactions (149). Exoacting dextranases preferentially attack the dextran polymers at their nonreducing ends, moving down the chains, liberating glucose and isomaltose.
The hydrolytic action terminates when they reach either an a 1-3 or a 1-4
branch point (188). Exo-dextranase produce large limit dextrans and
therefore have limited commercial importance. Exo-dextranases show the
same apparent Km for dextran regardless of its size (147).
Endo-dextranases bind randomly to the substrate and attack the
internal a-(1-6) linkages. The a-(1-6) linkages near branch points are
recalcitrant to attack. The products of endo-dextranase action are branched
and isomalto-oligosaccharides (149, 188). The apparent Km values of these
enzymes are inversely proportional to the molecular weights of the dextran
substrates, where affinity for high molecular weight dextran is much larger
than for low molecular weight dextran. Endo-dextranases are used
commercially both in sugarcane processing and for dental plaque removal.
Commercial dextranases are produced by fermentation from either
Penicillium sp. (Dextranase Novo 25L) or Chaetomium sp. (Dextranex).
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Lipomvces starkeyi. an ascosporogenous yeast, also produces an
endo dextranase. This yeast has been used in food related applications and
is not known to produce antibiotics or toxic metabolites (143). Lipomvces
dextranase has been demonstrated to be an effective agent for removing
dextran during sugar processing (93). The dextranase from L starkevi
ATCC 20825 has been purified and characterized (82, 94, 95). It is a
glycoprotein and is composed of multiple isozymes.
Except for a few bacterial dextranases (8, 12), microbial dextranases
are inducible. Koenig and Day (94, 95) reported on a derepressed mutant of
Lipomvces starkevi that showed elevated dextranase yields. However, they
could not obtain derepressed and a constitutive dextranase producing
mutant.

VI. Electron microscopy of dextran
The most thoroughly investigated dextrans are those produced by L
mesenteroides and S. mutans. Because of their commercial importance
there is voluminous literature devoted to the production and chemical
structure of L. mesenteroides dextran. However, there are relatively few
microscopic studies of this organism and / or of the dextrans it produces.
Most dextrans studied with electron microscopy are insoluble
dextrans. All electron microscopy studies used TEM. The exposure of L.
mesenteroides to sucrose leads to the induction of dextransucrase and the
initiation of dextran synthesis. These events are accompanied by dramatic
morphological changes on the surface of the cell wall. These surface
changes were demonstrated using ruthenium red (107) or reduced osmium
tetroxide (2) during fixation. The cell wall of MRS (38) media-grown
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mesenteroides B-512 cell is covered with a layer of material that often has
the appearance of a mass of tangled filaments. When transferred to media
containing sucrose, the surface coat (capsule) increases in thickness and
undergoes internal reorganization. The result is a uniform layer of very fine
filamentous material in which radically arranged rods are visible. In .L.
mesenteroides NRRL 1118 grown on sucrose, the major visible component
is a fibril (9 - 10 nm diameter), whose center is completely electron lucent but
whose surface is covered with fine, electron dense material. Fibrils are seen
solid but may be regarded as hollow tubules. These fibrils sometimes
branch, are randomly oriented and are always associated with filamentous
material. Although some capsules consist entirely of this fibrillar material, in
most cases there is a clearly defined zone adjacent to the bacterium in
which two other dextran components are visible. One of these is refered to
as globular dextran since it takes the form of spherical aggregates (100 110 nm diameter) of tightly packed material. The axis of each globule is
traversed by a fibril. The other dextran that can be distinguished appears as
a tightly packed reticulum of filaments and may be regarded as a matrix in
which the globular and fibrillar dextrans are embedded.

VII. Mixed culture
The science of microbiology has developed from the study of pure or
monospecies culture. Microorganisms in natural environments exist, with
very few exceptions, as complex, multispecies communities. Traditional
microbial processes, such as food and beverage fermentations and waste
treatment, are almost invariably the consequence of mixed microbial action.
In some fermented foods, the essential microorganisms have been identified
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and the biochemical transformations that they conduct have been described.
In most mixed fermentation processes few studies have been conducted
either at the microbial or the biochemical level (22, 172, 189). The number of
defined, deliberately constituted mixed cultures deployed in the fermentation
industry is small but include uses in such diverse areas as the treatment of
xenobiotic-containing wastes (20, 166), single cell protein production (103),
biotransformations (198) and food fermentations (40). The advantages of
using mixed microbial fermentations over monoculture includes a greater
range of substrate use, increased productivity, improved culture stability to
adverse operating conditions, resistance to contamination, and a single step
formation of complex products. Mixed cultures are resistant to contamination.
In a well-balanced mixed culture, all the ecological niches are occupied; a
contaminating organism has, therefore, to compete for scarce resources with
already well-established organisms (160). Many useful products can be
formed only in mixed culture (132, 133). Various terms are used to denote
the different interactions, such as, competition, commensalism, mutualism,
synergism, predation, amensalism, neutralism, symbiosis and parasitism
(125).
The demand for controlled size dextrans are increasing. However, the
traditional process has not changed for over 40 years. This is a batch
fermentation, acid hydrolysis followed by neutralization and repeated
alcohol fractionation. This process is time consuming and tedious. In
addition, yields and productivity are limited. We undertook to develop a new
process for producing clinical (or controlled size) dextran that would be
simple and have high productivity. A mixed culture fermentation utilizing
Lipomvces starkevi and Leuconostoc mesenteroides was designed. L

34

starkevi produces a dextranase and L. mesenteroides produces the
dextransucrase. By controlling the growth of both organisms and enzyme
reaction conditions it was possible to control product size. In addition,
productivity was increased.

MATERIALS AND METHODS

I. Organisms and growth conditions
Lipomvces starkevi ATCC 74054 is a derepressed and dextranase
constitutive mutant derived from Lipomvces starkevi ATCC 12659 by ethyl
methane sulfonate mutagenesis.

ATCC 12659 was maintained at room

temperature on WW medium (94) containing 0.1 % yeast extract (WWY), 1%
dextran as carbon source and 1.2 % agar, pH 4.5. WW salts had the
following composition per gram per liter of tap water: (NH4)2SC>4, 5.0;
KH 2 P0 4l 1.5; MgS04.7H20, 0.1; NaCI, 0.1; and CaCI2.2H20, 0.1.
Lipomvces ATCC 74054 was maintained on slants at room temperature on
LW medium containing 1 % (w/v) soluble starch as a carbon source and 0.5
g/l (w/v) 2-deoxy-D-glucose. LW medium consists of 3 gram per liter of tap
water of yeast extract; and 3 gram per liter of tap water of KH2P04- The pH
of this media was adjusted to 4.5 with HCI. Cultures were transferred
biweekly. Leuconostoc mesenteroides ATCC 10830 (NRRL B-512) is the
normal organism for dextran production. Leuconostoc mesenteroides ATCC
10830 was maintained at room temperature on All Purpose Broth (APT,
Difco., Detroit, Ml) agar or LW medium containing 2 % (w/v) sucrose as a
carbon source and pH was adjusted to pH 5.8 with HCI. It was transferred
biweekly.

II. Selection of ATCC 74054
Cells of Lipomyces starkevi ATCC 12659 (approximately 5 x 108
cells) were collected from slants (5 days old, grown on WWY containing
dextran) and suspended in 6 ml of sterile sodium phosphate buffer, pH 7.0.
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Then, 0.7 ml of the cell suspension was added to 3 ml of buffer, and 100 nl
(1.17 g/ml) of ethyl methane sulfonate (EMS, Sigma Chemical Co.). The
cells were exposed to EMS for 1.5 hours at 30°C. The treated cell
suspension (0.2 ml) was then transferred to 8 ml of sterile 10 % sodium
thiosulfate to quench the EMS. The treated cells were sedimented (x 10,400
g), washed twice with sodium phosphate buffer and plated onto selection
plates.
Selection plates were bi-layer agar plates. The upper layer was
composed of WWY with 1 % (w/v) agar, 0.05 % (w/v) 2-deoxy-D-glucose,
and 1 % (w/v) carbon sources. The carbon source was sucrose, glucose,
fructose or starch. The media was adjusted to pH 4.5 before sterilization. The
bottom layer was composed of citrate phosphate (0.05 M) buffered bluedextran (0.1 %) with agar (1.5 %), pH 5.5. The colonies which formed clear
zones (110) in the bottom layer were selected and transferred to fresh bilayered plates. Confirmation of dextranase constitutive activity was made by
monitoring enzyme production in shaking flask cultures (WWY medium
containing 1% starch, glucose, fructose, sucrose or maltose as carbon
source).

III. Enzyme production and purification
Lipomvces starkevi ATCC 74054 dextranase was produced in 1.2 liter
fermentation in a 2 liter Bio Flo II Batch / Continuous Fermentor (New
Brunswick Scientific Co.) or in 20 liter batch cultures in a 24 liter Microferm
Fermenter Model CMF 128S (New Brunswick Scientific Co.) on LW medium
containing 1 or 2 % carbon sources. The pH was normally maintained at 4.0
by the automatic addition of 3.0 N NaOH. The aeration rate was set normally

at 1.0 wm (volume/volume/min), and temperature was maintained at 30 °C.
The stirring rate for all fermentation was 100 rpm. Inocula were 1.5 % (v/v)
cultures (shake flask) grown for 48 hrs in LW medium containing 1 %
glucose or other carbon source. Growth was monitored by absorbance at
660 nm.
ATCC 74054 culture supernates were concentrated by ultrafiltration
from 1.2 L to 50 ml with a 10 KDa cut-off stacked membrane (Diaflo, Amicon
Co.). A Carboxymethyl-Sepharose column (75 cm x1.5 cm) was prepared
and equilibrated with 0.02 M potassium phosphate buffer (pH 6.0). The 10
KDa (kilodalton) concentrate, 1.5 ml (20 mg protein/ml), was applied to the
column and then eluted with 0.5 M NaCI. The dextranase active fractions
were pooled and then proteins were further fractionated on a BiO-RAD A0.5 m column (70 cm x 2.6 cm) which was prepared and equilibrated with
0.05 M citrate phosphate buffer (pH 5.5). CM (carboxymethyl)-Sepharose
concentrate (3 ml) fraction was applied to this column (4 mg protein/ml). The
fractions with dextranase activity were pooled. This preparation was used for
the characterization of the dextransucrases.
Leuconostoc mesenteroides was grown in 1.2 liter batches in a 2 liter
Bio Flo II Batch / Continuous Fermentor(New Brunswick Scientific Co.) with
LW medium containing sucrose (1- 3 %). The pH was maintained at 5.8 by
the addition of 3.0 N NaOH. The aeration rate was set to 0.5 wm, and the
temperature was maintained at 28 °C. The stirring rate was 100 rpm. Inocula
were 1 % (v/v) with cultures (shake flask) grown for 24 hrs in LW medium
containing 1 % glucose or sucrose as carbon source. After removal of the
cells by centrifugation (20 minutes, x 9,600 g), the extracellular
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dextransucrase was purified by aqueous two-phase partition with PEG, Mr
1500, as reported by Otts and Day (134).

IV. Enzyme assays
Dextranase activity was determined by incubating the enzyme for 20
minutes at 50 °C with 2.0 % (wA/) Dextran T-2000 (Sigma Chemical Co.) in
0.05 M citrate/phosphate buffer, pH 5.5. The level of enzyme activities were
determined from the rate of increase in amounts of reducing sugars as
measured by the 3, 5-dinitrosalicylic acid method (174) using a isomaltose
standard. One unit of dextranase was defined as the amount of enzyme
which liberates 1 nmole of isomaltose equivalents in one minute under the
described conditions. Amylase was assayed by the same method except
that 2 % soluble starch was substituted for the dextran as the enzyme
substrate.
Dextransucrase activity was determined from the rate of fructose
production, detected by HPLC or by ion chromatography (Dionex
carbohydrate analyzer, Dionex Co.). Dextransucrase reaction mixture was:
sucrose, 150 mM; CaCi2, 1 mM; sodium acetate pH 5.2, 100 mM.
Exogenous dextran was not added. One unit is defined as the amount of
enzyme that catalyses the formation of 1 fimole of fructose per minute at 30
°C and pH 5.2. For HPLC analysis, a Bio-Rad HPX-87N, 300 x 7.8 mm
column, was used. The sugars were detected using a Waters 410 differential
refractometer. The column eluent was 0.004 M sodium sulfate solution was
used as eluent, pumped at 0.1 ml / min by a Waters chromatographic pump.
Temperature of the column was maintained at 85 °C with a Waters TCM
temperature controller. A 20 nl sample was injected either manually, or

39
automatically with a Waters 712 Wisp automatic system. The refractive index
was recorded and chromatographic integration was by a Spectra - Physics
SP 4270 integrator. Fructose was determined with a DIONEX carbohydrate
analyzer (DIONEX Corporation). The column was a Carbopac PA 1, 4 x 250
mm (DIONEX Corporation). NaOH 100 mM solution was used as eluent and
pumped at 1.0 ml / min by a Gradient pump. A 50 fil sample was injected
and signal was detected with a Pulsed Electrochemical Detector. Integration
was done by a Dionex 4400 Integrator. Total carbohydrate was determined
by phenol-sulfuric acid assay (41).
Levansucrase activity was measured by the following the rate of
reducing sugar produced from raffinose. The dextransucrase assay system
as determined above was used, with the substitution of 150 mM raffinose for
the sucrose. Reducing sugar was measured by the DNS (3,5 dinitrosalicylic
acid) method.
Protein was determined with a BIO-RAD protein assay kits as
described by manufacturer (Bio-Rad Co.).

V. Enzyme characterizations
The pH optimum for dextranase was determined from reaction
incubated at 50 °C for 15 minutes. The pH's of the substrate solutions
ranged from 2.5 to 7.5. The pH of the reaction mixtures was examined both
before and after incubation, and it was found not to change.
The dextranase's temperature optimum for activity and stability was
determined by incubating reactions at various temperatures and then
measuring residual activity at the optimum temperature.
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End products of the dextranase reaction were analyzed by using
dextranase (100 IU) and 10 ml of 2 % dextran T-200Q (Sigma Chemical Co.)
at 40 °C, pH 5.5. This reactions were complete after 24 hours. Samples
were then filtered through a 0.22 |xm membrane and assayed by HPLC for
oligosaccharide composition. The HPLC used was a Varian Vista 5500 with
a refractive index detector. The column employed for separation was a
Rainin NH2-Dynamax 60A. The HPLC conditions were: solvent-acetonitrile
: water (50 : 50), column temperature 25 °C, flow rate 0.5 ml / min, column
pressure 64 atm, with a 20 [aI sample injection.
Thin layer chromatography was conducted on either Whatman K5
0.25 mm silica gel plates, or on E. Merck plates (0.25 mm) of 1:1 silica gel
60-Kieselguhr. Multiple ascents were made in one of the following solventmixtures : A, 5:2:4:4 (v/v/v/v) n-propanol: nitromethane: acetonitrile: water, B,
4: 1(v/v) acetonitrile: water and C, 3:1:1 (v/v/v) ethanol: nitroethane: water.
Detection was with 20 % sulfuric acid in methanol, or with naphthoresorcinol
sulfuric acid (mixture of equal volumes

of 0.2 % naphthoresorcinol

dissolved in ethanol and 30 % sulfuric acid), heated for 10 - 15 min at 100110 °C. D-Glucose, isomaltose, isomaltotriose (Sigma Chemical Co.)

and

isomaltooligosaccharides were used as standards.

VI. Dextran size and quantity determination
Dextran sizes and polydispersity indices were determined by
measurement of multiangle light scattering intensities using a DAWN Photometer (Wyatt Technology, Ca). The DAWN GPC detector measures the
scattering intensities of a sample at 15 discrete angles and transmits the
data to a computer for digital conversion and subsequent processing under
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control of the ASTRA™ (or ASTRA 202) software (Wyatt Technology, Ca).
Cumulative dextran molecular weight distributions were obtained using an
"Enhanced-analytical-software-inplementation" (EASI™) program (Wyatt
Technology, Ca). Acetone and cyclohexane were used for instrumental
calibration. Concentrations were obtained from a Waters model 410
Differential Refractometer (Millipore Corporation, MA). Dextran sizes were
based on the GPC calculation and the following external standards; T10,
T40, T500, and T2000 (Pharmacia Co., Sweden) dextrans. Sample injection
volumes were 100 \i\ and the GPC column was a Ultrahydrogel Linear
column (Waters, Millipore Corporation, MA). The running buffer was 0. 1 M
NaNC>3, and the temperature was 45 °C.
The total sugar amount was assayed by the phenol - sulfuric acid
assay (PS) (41). Glucose, fructose and T10 (average M.W. 10,000,
Pharmacia,Uppsala, Sweden) were used as standards. Saccharimeter
assays using a saccharimeter (Autopol IIS, Automatic Saccharimeter,
Rudolph Research, Fairfield, New Jersey) were also used for dextran
quantification. Dextran T 10, T 40, T 70, T 2000 (Pharmacia, Uppsala,
Sweden) and T 150 (from Dr. Patel, Chemdex Inc., FL) were used as
standards. Dry weights were determined by heating samples mixed with
known amount of pre-determined sand to prevent caking by heating at 110
°C to constant weight.

VII. Dextranase addition effect on dextransucrase activity
L. starkevi ATCC 74054 dextranase (0.1 lU/ml), partially purified, was
added to dextransucrase preparations (0.32 lU/ml) containing 6 mg/ml of
carbohydrate. This mixture was incubated for 5 hours or 2 days at room
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temperature. Then the mixture was dialyzed (5,000 M.W. exclusion
membrane) for 4 hours against total 12 liters of deionized water at 4 °C.
Dextransucrase substrate was then added and it was incubated for 1 hour at
30 °C.

VIII. Optimization of mixed culture fermentation
Unless otherwise specified the following conditions were used for all
mixed culture fermentations : LW 3 media (which composition in the gram
per liter of tap water is yeast extract; 8.5 and KH2PO4; 5) containing 0.003 %
antifoam (Dow Corning antifoam 1410, 10 % active industrial defoamer,
Dow Corning, Ml), pH 5.2, temperature, 28 °C, aeration; 1.0 vvm, agitation;
100 rpm. Inocula were 1.5 % with ratios of L. mesenteroides to L. starkevi of
3:1 (or 4 : 1). Sucrose concentration was 15 or 20 % (w/v). Sucrose was
added by either a discontinuous addition or as a single addition at
inoculation. Initial sucrose concentration for discontinuous addition was 3 %
(w/v).
a. pH - Shake flask cultures were used to screen pHs ranging from
4.5 to 7.5. Then 1.2 liter fermentations were tested at pH's of 5.2, 5.4, 5.6 and
6.4. Total dextran yields and clinical dextran yields were determined. Cell
numbers were estimated using a Petroff-Hauser chamber. Doubling times
were determined from log phase growth after final sucrose addition.
b. Temperature - Three temperatures , 26 °C, 29°C, and 32°C, were
examined by 1.2 L fermentation.
c. Yeast extract - The effect of yeast extract concentrations ranging
from 0.3 % to 0.9 %, to dextran production were examined in 1.2 L
fermentations.
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d. CaCl2 - CaCl2 effect on dextransucrase and dextranase production
was examined. CaCfc (0.2 mM) was added to the culture medium before
final sucrose addition (21 hrs).
e. Sucrose concentrations - Effect of sucrose concentration (15 %, 20
%, 25 % or 30 %-w/v) on dextran production and clinical dextran formation
were studied. Discontinuous addition frequencies depend on the final
sucrose concentration achieved. The frequencies are followed; 15 %
sucrose fermentation - 3 %(w/v, at 0 hr) and 12 % sucrose between 12 and
14 hrs post inoculation, 20 % sucrose fermentation - 3% (at 0 hr), 9 %
(between 12 and 14 hrs) and 8 % sucrose at 21 hrs; 25 % sucrose
fermentation - 3 % (at 0 hr), 9 % (between 12 and 14 hrs) and up to 13 %
sucrose at 21 hrs, 30 % sucrose fermentation - 3 % (at 0 hr), 9 %(at 12 hrs),
9 % (at 21 hrs) and 9 % sucrose at 29 hrs. A single addition was the addition
of all the sucrose for the fermentation at inoculation.
f. Cell number ratios - Different ratios of L. mesenteroides to L.
starkevi (ranging from 1.4/1 to 48 / 1) in the inoculation were studied for
their effects on dextran productions. These ratios were achieved by mixing
different amounts of separate cultures containing a known number of cells to
provide the mixed culture inoculum.

IX. Viscosity comparisons of products
Viscosity was measured with a Brookfield synchro-Lectric viscometer
model LVT

(Brookfield Engineering Lab., Massachusetts) using spindle

(number 1). The unit was a centipoise (mPa.s).
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X. Maltose and dextranase addition effects on Leuconostoc fermentations
Maltose (3 % w/v) was added to Leuconostoc fermentations (sucrose
12 %) and the dextran size distributions were examined. The maltose was
added when the residual sucrose was 9 %.
Dextranase (0.5 lU/ml) was added to Leuconostoc fermentation. The
dextran size distributions were examined with time. Dextranase was added
either when the residual sucrose was about 8 % or when all the sucrose had
been consumed (after 36 hrs).

XI. Exogenous dextran addition
Large dextran (average 1.15 x 106) and low molecular weight
(average 40,000) dextran (1 % - w/v) were added to Leuconostoc grown in
13 % sucrose when 10 % residual sucrose remained. Dextran size
distributions and dextransucrase activities were compared to matching
cultures where exogenous dextran was not added in 15 % sucrose.

XII. Dextran hydrolysis
Comparative acid and enzymatic hydrolysis of dextrans produced by
mixed cultures were conducted. Acid hydrolysis used 1 N HCI and
enzymatic hydrolysis used ATCC 74054 dextranase. The hydrolysis was
halted at time intervals and samples were chromatographed on Whatman
K5 0.25 mm silica gel in solvent A; detection by 20 % sulfuric acid in
methanol. Acid hydrolysis was 5 % polymer solutions incubated at various
time in the 110°C oven and enzymatic hydrolysis used dextranase (0.5
lU/ml) on 0.2 M buffered 3 % polymer solutions. Fermentation final sugar
concentration was 15 % in case of pure culture, and 5 % maltose was
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added to 10 % sucrose in case of maltose addition. In case of starch
containing mixed culture, 3 % was starch and 12 % was sucrose. LW 3
medium was used. Maltose and starch were added at second sucrose
addition point. Panose, glucose, and isomaltooligosaccharides were used
as standards.

XIII. Dextran precipitation from cultures
a. Leuconostoc fermentations - At the end of the fermentation
isopropanol was added, up to 50 % (v/v, usually less than 50 %). After
decantation the precipitate was dissolved with distilled water and reprecipitated with isopropanol (50 %). It was then re-dissolved in distilled
water and boiled it to remove residual solvent. The solution was filtered
through a 0.45 urn pore size membrane.
b. Mixed culture fermentation - After harvesting, the culture was
centrifuged for 20 minutes (x 10,400 g)to remove the cells. Isopropanol was
used to precipitate the dextran, the concentration depended on the dextran
size and dextran concentration. Usually the isopropanol was added up to 67
% (v/v). The precipitate was re-dissolved in distilled water (less than half
volume of its initial volume) and re-precipitated. Re-dissolved with distilled
water and boiled to remove solvent. The final dextran solution was filtered
through a 0.45 urn pore size membrane.
c. Salt effects on dextran precipitation - Varying amounts of KH2PO4
and MgS04 were added to the dextran solutions before methanol, ethanol
or isopropanol precipitations. Dextran solutions were T 2000 (10 % w/v Pharmacia, Uppsala, Sweden), industrial grade dextran (5 %, Sigma
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Chemical Co.) and mixed culture dextran (10 %). The solvents were added
67 % (or less). The salts concentrations ranged from 0 to 0.4 % (w/v).

XIV. Residual dextranase activity in the dextran preparation
Dextran solutions (10 %) were left for 4 days at room temperature and
then examined by GPC. Dextranase inactivation (by acid) was conducted by
dropping the pH to 1.7 with concentrated HCI and then incubating at room
temperature for 1 hr.

XV. Activated charcoal filtration
Activated charcoal (Sigma Chemical Co.) was packed in a column
(150 x 15 mm). Dextranase was mixed with 10 % dextran solutions (2.7
lU/ml, 52 mg/ml of protein). The dextrans were T 40, T 500 or T 2000
(Pharmacia,Uppsala, Sweden). The mixture was filtered through the
activated charcoal column. Samples were also boiled for 5 minutes or
acidified (pH 1.7) prior to filtration. Residual activity and protein
concentration of the filtrate were determined.

XVI. Electron microscopy of dextrans
Each sample (5 or 10 ml) was loaded into a 13 mm syringe fitted with
a polycarbonate filter of 0.2 urn pore size. Samples were made 2 % (v/v) with
glutaraldehyde. The syringe contents were expressed and then 2 ml of 2 %
glutaraldehyde in 0.1 M cacodylate buffer, pH 7.0 were added to the syringe.
Total glutaraldehyde fixation time was about 30 minutes.
The filter is washed with 0.1 M cacodylate buffer about 2 ml through
the filter over a 15 minute. This was followed by 1 ml of 2 % OSO4 expressed

over 25 minutes and then distilled water 2 ml over 5 minutes. Then 2 ml of
0.5 % uranyl acetate was expressed over 20 minutes in the dark and
washed with 1 ml distilled water

over 20 minutes. The filter was then

removed.
Ruthenium red (RR) solution composed of 0.15 % (w/v) RR, 0.04 %
glutaraldehyde, 0.04 % OSO4 and 0.002 M cacodylate buffer was used for
staining. Then the above fixation procedure was followed. Specimens (yeast
and/or bacterial culture broths) were dehydrated in successive 5 minutes
steps with 50 %, 75 %, 87 %, 93 %, 95 % and absolute ethanol. For
scanning electron microscopy (SEM) each specimen was coated with goldpalladium in a hummer sputter coater (Technics). The microscopes used
were either a Cambridge Stereoscan 260 SEM (Cambridge Instrument Co.)
and a JOEL 100 CX SEM.

RESULTS

I. Studies on a constitutive dextranases mutant

(1) Mutant isolation
A Lipomvces mutant, ATCC 74054, constitutive for dextranase
production was selected after EMS mutagenesis by zone clearing on blue
dextran agar plates. The wild type, Lipomvces starkevi ATCC 12659, does
not produce any clearing on blue dextran selection plates (Figure 3 - A).
Dextranase activity was not detected under the parental colonies after
colony removal. The wild type did not show any evidence of clearing blue
dextran even after 5 days of incubation, however, the mutant (ATCC 74054)
showed zone clearing after 2 days. The colony sizes of both strains were
similar at the same time period. Dextranase production by ATCC 74054 on
various carbon sources (dextran, soluble starch, sucrose and fructose) is
shown in Figure 3 - B. Clearing was seen with all substrates.
Dextranase production by ATCC 74054 in liquid culture was assayed
in shake flasks and in 20 L fermentations cultures (Table 1). Lipomvces
starkevi ATCC 74054 produced approximately equivalent amounts of
dextranase when grown on glucose, fructose, maltose and sucrose. When
grown on starch dextranase production was about 4 fold higher than when
grown on sucrose. Different starches produced different amounts of
dextranase, 0.045 lU/mg cells on Soluble Starch versus 0.057 lU/mg on
Corn Starch. This strain produced more enzyme (0.139 lU/mg cells) than the
parental strain (0.111 lU/mg cells) on 1 % dextran.
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Figure 3.

Phenotype of L. starkevi and a dextranase mutant on blue
dextran agar plates.
A) (1) Wild type (ATCC 12659) and (2) mutant ATCC 74054.
Arrows indicate the spot where colonies were removed.
B) ATCC 74054 grown on dextranase selection plates
containing dextran (1), sucrose (2), starch (3) and fructose (4).
All carbon sources were 1 % (w/v).
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Table 1.
Growth and dextranase production by Lipomvces
Strain

ATCC 12659

ATCC 74054

Carbon
Source (1 %-w/v)

Starch (SF)

Cell Mass
(mg/ml)

Dextranase
(lU/mg cell)

7.4

0.000

Dextran (20 L)

31.4

0.111

Starch (SF)

12.3

0.041

Starch (20 L)

30.2

0.086

Starch (2 %, SF)

17.6

0.045

(2%, SF)

19.3

0.057

Glucose (SF)

10.1

0.010

Fructose (SF)

9.5

0.010

Maltose (SF)

8.0

0.008

Sucrose (SF)

10.9

0.011

Dextran (SF)

13.4

0.142

Dextran (20 L)

29.6

0.139

Corn Starch

Cell mass; Cell dry weight, Carbon source concentration was 1 % (w/v) except indicated,
Starch; Soluble Starch, SF; Shake flask cultures after 3 days (late-log phase), 20 L; 20 L
fermentation after 4 days (stationary phase), Dextranase activity standard deviation (s.d.) for
SF - < ± 0.002 and for 20 L < ± 0.001.
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(2) Mutant characterization
The ability of a Lipomvces to grow and produce dextranase in a
media with sucrose, fructose, and high osmotic pressure is important for use
in a Leuconostoc mixed culture system. Growth rates of ATCC 74054 on
glucose and fructose were determined (Figure 4). ATCC 74054 showed
similar specific growth rates (1.2164e-4 and 1.2143e-4 [d(mg cells)/dt] at log
phase) on both glucose and fructose. The rate of disappearance of the sugar
(glucose or fructose) was also similar (Figure 5). An ability of the Lipomvces
to grow on fructose is important for mixed fermentations because 52 % of
sucrose is fructose. In fact, the mutant showed no preference for one carbon
source over the other as both disappeared from the medium at the same rate
(Figure 5). Not surprisingly ATCC 74054 grew significantly faster on 15 %
sucrose than on 30 % sucrose (Figure 6). After the bulk of the sucrose was
consumed (120 hours) growth differences disappeared.

(3) Dextranase characterization
Dextranase production as a function of sucrose concentration is
shown in Figure 7. Although the growth slowed as sucrose concentration
increased, dextranase activity increased as sucrose concentration
increased. At 30 % sucrose, after 148 hours, enzyme activity was 3.1 fold
greater than on 7.5 % sucrose.
The pH and temperature optima for ATCC 74054 dextranase are
shown in Figures 8 and 9. Optimum pH and temperature for the dextranase
produced on fructose, starch or dextran were the same, a pH optimum of 5.5
and a temperature optimum of 55° C. The pH optimum was lower than the
enzyme from the parental strain which has an optimum pH at 6.5 (82),
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Figure 4.

Growth of ATCC 74054 on glucose (open circle) and
fructose (closed circle).
LW medium, Initial pH; 4.5, Sugar concentrations; 1 % (wA/).
Specific growth rate constants [d(mg cells) / dt] at the log
phase are 1.2164e-4 and 1.2143e-4 on glucose and fructose,
respectively. Bar indicates standard deviation.
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Figure 5.

Sugar consumption by ATCC 74054 on mixed carbon sources
(1 % each).
Open circle; Residual glucose per mg cells in the culture,
Closed triangle; Residual fructose per mg cells in the culture.
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Figure 6.

Growth of ATCC 74054 at various sucrose concentration.
(A) Growth of ATCC 74054 at times on various sucrose
concentrations (w/v).
LW medium, pH 4.5, temperature, 30 °C, shake flask cultures.
(B) Growth of ATCC 74054 at various sucrose concentration at
any given time. LW medium, pH 4.5, temperature, 30 °C, shake
flask culture.
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Figure 7.

Dextranase production by ATCC 74054 at various sucrose
concentrations.
LW medium, Initial pH 4.5, temperature, 30 °C, shake flask
culture, Dextranase activity; lU/mg cells, open circle is
dextranase specific activity after 2 days or closed circle is
dextranase specific activity after 6 days.
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Figure 8.

Optimum pH's for dextranases produced on different
carbon sources (1 %, w/v).
Relative activity is the % of dextranase activity at test pH to the
activity at optimum pH (Medium; WWY). Relative dextranase
activity on fructose (open circle), starch (closed circle) or
dextran (open triangle) is shown.
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Temperature (°C)

Figure 9.

Optimum temperature (°C) for dextranases produced on
different carbon sources (1 %, w/v).
Relative activity is the % of dextranase activity at test
temperatures to activity at optimum temperature. Relative
dextranase activity on fructose (open circle), starch (closed
circle) or dextran (open triangle) is shown.
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whereas the temperature optimum is the same as the parental strain
enzyme. The temperature stability of the dextranases is shown in Figure 10.
The dextranase produced on fructose showed higher thermal stability than
that produced on starch or dextran. At 65 °C, dextranase produced on
fructose retained 50 % of its original activity after 30 minutes incubation,
however, the dextranases produced on starch or dextran contained less
than 20 % of their original activity. It is probable that these dextranases, like
the parental strain enzyme, are composed of multi-isozymes with different
properties (82).
This dextranase gave different end product profiles when produced
on sucrose rather than dextran (Table 2). When produced by dextran grown
cultures

the

enzyme

produced

more

glucose

and

less

isomaltooligosaccharides from dextran than the equivalent enzyme
prepared from sucrose grown cultures. A lower glucose formation is
preferred for a mixed culture fermentation because isomaltose is a better
acceptor for dextran production. Glucose is not a dextransucrase substrate
but it acts to decrease dextran yields.

(4) Amylase production
Unlike the parental strain amylase was produced by ATCC 74054
throughout the growth phase (Figure 11) on sucrose. The specific activities
of both amylase and dextranase were highest at mid-log phase and then
decreased with time. Amylase was produced on dextran just as dextranase
is produced on starch (Table 3). On sucrose ATCC 74054 produced
amylase at a level about 15 % of the amylase produced on starch. On
dextran, amylase production was 86 % of the level it was on starch.
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Figure 10.

Temperature stability of dextranases produced on different
carbon sources (1 %).
Samples were incubated for 30 min at the test temperature.
The relative activity is the activity remaining after incubation
upon assay at 50 °C. Relative dextranase activity on fructose
(open square), starch (closed circle) or dextran (open triangle)
is shown.
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Table 2.
Hydrolysis products of ATCC 74054 dextranases

Reaction End Products (%)
Enzyme source

Glucose

Isomaltose

Higher IMn*

Sucrose DXase

11.9

62.1

26.0

Dextran DXase

72.4

0.0

27.6

* Higher isomaltooligosaccharides; Degree of polymerization; > 4, DXase : Dexranase.
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Growth (open circle), dextranase (open triangle), and amylase
(closed triangle) production by ATCC 74054 on sucrose (2 %).
LW medium, Initial pH 4.5, temperature, 30 °C, shake flask
culture, Dextranase activity; lU/mg cells.

63
Table 3.
Dextranase and amylase production by ATCC 74054 on sucrose, starch or
dextran
Carbon Source
(1 % - wN)

Cell Mass
(mg/ml)

Dextranase
(lU/mg cell)

Amylase
(lU/mg cell)

Sucrose

10.9

0.015

0.022

Starch

12.8

0.083

0.149

Dextran

10.1

0.150

0.128

Cell Mass; Cell dry weight, Samples were measured at maximum dextranase activity (sucrose;
40 hours, starch and dextran; 72 hours), 1.2 L fermentations.
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II. Dextransucrase

(1) Growth and dextransucrase production by L. mesenteroides in
high sucrose
Growth and production of dextransucrase bv L. mesenteroides were
examined (Figure 12) in 15 % and 30 % sucrose. 15 % sucrose is used
commercially for dextran production, and 30 % sucrose where dextran yields
are reported to decrease significantly (5). Dextransucrase

enzyme

production also followed exponential growth; its activity was highest in the
late log phase. More dextransucrase activity was found in 30 % (1.18 lU/ml)
than in 15 % (0.73 lU/ml) sucrose. Dextransucrase activity was also more
stable when grown in a 30 % culture than in a 15 % culture.

(2) Effect of dextranase on dextransucrase activity
The effect of ATCC 74054 dextranase on dextransucrase activity was
examined by adding dextranase (final activity of 0.1 Ill/ml) to partially
purified dextransucrase preparations. The controls were samples containing
only dextransucrase. After incubation (5 hours and 48 hours at room
temperature) in the absence of substrate, preparations were analyzed for
total carbohydrate and then dextransucrase activity was determined (Table
4). Dextransucrase activity initially increased 2.6 fold upon dextranase
treatment. This increase disappeared after 48 hours, and total carbohydrate
decreased to 10 % of the control value. Control activity decreased after 48
hours 78 % of its original. There was no detectable dextransucrase
inactivation after 5 hours incubation.
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Growth (circle) and extransucrase production (triangles)
ot L. mesenteroides at 15 (open) and 30 % (closed) sucrose.
Organisms were grown in LW 3 media with sucrose 15 or 30 %
(wA/) as carbon source. DSase (dextransucrase) activity (lU/mg
cells) was determined by measuring the fructose released from
sucrose by the reaction.
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Table 4.
Dextranase activation effect on dextransucrase activity

Dextransucrase
(IU/ml)
Treated*

Total carbohydrate
Control

(ma/ml)
Treated*

Incubation
Time

Control

5 hrs

0.32

0.83

6.0

3.0

(±0.02)**

(±0.03)

(±0.2)

(±0.1)

0.25

0.27

6.0

0.6

(±0.02)

(±0.02)

(±0.2)

(±0.1)

48 hrs

Treated; Dextransucrase preparation added with dextranase, ** Standard deviation.

I
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III. Optimization of mixed culture fermentation
A mixed culture fermentation system was designed to produce
controlled size dextrans. This process requires the establishment of a
microbial consortia of Lipomvces starkevi ATCC 74054 and Leuconostoc
mesenteroides ATCC 10830 (Figure 13). By controlling growth and enzyme
production of both organisms, product size can be controlled. Parameters,
especially those which affect growth and enzyme activity, must be optimized
to produce clinical size dextrans. For this process, both strains are initially
grown independently on sucrose to prepare an inoculum and then mixed.
Dextran fermentation is then allowed to proceed normally. At the desired
time (and molecular size) the fermentation is harvested.

(1) Media requirements - yeast extract and CaCl2
Both total and clinical dextran yields depended on the concentration
of yeast extract in the medium (Table 5). Differences were detected between
pure and mixed cultures. For yeast extract concentrations between 0.3 % to
0.9 %, L, mesenteroides pure cultures produced from 52 to 74 % of the
theoretical yield of dextran (most of it was high molecular weight dextran).
The highest yields were obtained with 0.9 % yeast extract. 100 % of the
theoretical yield of dextran is about 48 % of sucrose used. The total dextran
yields in mixed culture fermentations were comparable to pure culture. On
0.9 % yeast extract media the dextran productivity (75.3 %) of mixed culture
was similar to or higher than that of pure culture (73.6 %). Mixed culture
fermentations also produced more dextran than pure culture on both 0.3 and
0.75 % yeast extract media, respectively. L. mesenteroides cell numbers

68

Figure 13.

Phase-contrast micrograph of mixed culture broth.
Twenty one hours after co-inoculation showing mixed culture
aggregation. Ruthenium red treated (x 1,050), bar = 10 jim.

Table 5
Effect of yeast extract on dextran yield

0.3
Total Dextran
Yield (%)
Clinical
Dextran (%)
Lm cell #
(x107)
Ls cell #
(x107)

%1

Pure Culture
0.75 %

0.9 %

0.3 %

Mixed Culture
0.75 %

0.9 %

51.8

66.1

73.6

70.4

71.9

75.3

NA

NA

NA

82.0

94.0

93.0

48

80

81

40

64

74

NA

NA

NA

9.0

8.0

7.4

DSase (lU/ml)

0.24

0.45

0.54

1.01

0.86

0.87

DXase (lU/ml)

NA

NA

NA

0.77

0.57

0.60

Total dextran (%); Average total dextran % of theoretical yield, standard deviation; (±2.2) and (± 1.5) for pure and mixed culture, respectively,
(average of GPC*, PS*, and Saccharimeter * assay - * GPC; Gel Permeation Chromatography, PS; Phenol-sulfuric acid assay), Clinical dextran
%; In mixed culture fermentation, clinical dextran portion of the total dextran produced (±1.5),Lm #; L. mesenteroides cell number in pure and
mixed culture fermentations (±0.05), DSase; Dextransucrase activity (Ill/ml) of pure and mixed culture fermentations (±0.02), Ls cell #; L
starkevi number in mixed culture (±0.04), DXase; Dextranase (lU/ml) activity in the mixed culture fermentation (±0.02), 1; % - w/v, NA; Not
appliable.
* Fermentations were done on15 % sucrose and data were obtained at 25 hours post-inoculation.
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were similar in mixed culture and in pure culture. However, dextransucrase
activities were higher in mixed culture. L. starkevi cell numbers also did not
show higher changes with changing yeast extract levels. Between 0.3 and
0.75 % yeast extract, dextranase activity decreased slightly. At the 0.75 and
0.9 % yeast extract, clinical dextran yields (%) were 94 and 93 % of
theoretical, respectively. Despite high dextranase and dextransucrase
activities with 0.3 % yeast extract, clinical dextran production was lower. It
appears that dextran was degraded when dextranase levels were in excess
over that necessary to produce acceptors. HPLC analysis showed an
increase in the amount of small oligosaccharides in 0.3 % yeast extract
mixed culture broths (83). A level of 0.85 % yeast extract was used in all
further mixed culture fermentations.
The production of dextransucrase by L. mesenteroides B-512(F) has
been reported to be stimulated (about 2 fold) by the addition of CaCl2 (0.005
%) (88, 159). The addition of up to 0.2 mM CaCl2 to the mixed culture
fermentation medium (21 hrs post-inoculation) produced no increase in
dextransucrase activity (after 26 hrs) (Table 6). Dextransucrase was more
stable at the end of fermentation (after 38 hrs) in the presence of CaCl2.
However, elevated dextransucrase activity is not a critical factor for the
mixed culture fermentations because all the sucrose is consumed. In the
absence of sucrose, dextransucrase will produce branched dextrans (126,
159). It has been reported that Ca++ and other divalent metal ions can also
act as branching factors (186). Toward the end of the mixed culture
fermentation, dextranase is required for low molecular weight (LMW) dextran
production. CaCl2 inhibits dextranase activity (Table 6, 93).
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Table 6.

Effect of CaCl2 on the production of dextransucrase and dextranase in
mixed culture
Time from
DSase Activity
CaCl2 Addition .
(hr)
Control^

nU/mlVL

DXase Activity

flu/ml^

CpntrQia

QaCI?
(0.2 mMI

(0.2 mM)

0

0.41

0.40

ND

ND

26

0.22

0.21

ND

ND

38

0.15*

0.22*

0.34**

0.1**

1. Dextransucrase activity, 2. Dextranase activity, 3. Without CaCl2 addition.Standard
deviations; * ± 0.02; ** ± 0.03, ND • Not determined.

(2) Effect of pH on the production of clinical dextran
The effect of pH on the production of dextran and clinical dextran was
examined in order to reconcile growth and reaction conditions for
dextransucrase and dextranase. L. mesenteroides grows and produces
dextransucrase best between pH 6.5 to 7.0 (51). L. starkevi grows well at pH
4.5 or below (93). Dextransucrase is produced throughout the growth phase
of L. mesenteroides (Figure 12) and ATCC 74054 dextranase is produced
from mid - log phase to early stationary phase (Figure 11). Both enzymes
have similar optimum pH's for activity and stability. The optimum pH for
dextransucrase is 5.2 and for ATCC 74054 dextranase is 5.5. To maximize
dextran production, growth and substrate consumption must be limited. The
effects of pH controlling on dextran productivity are shown in Figure 14. At
pH 5.4 the dextransucrase activity was highest (1.3 Ill/ml). A comparison
dextransucrase activities in pure and mixed cultures at pH 5.6 showed the
activity of dextransucrase in mixed culture was about 1.6 times higher. The
higher dextransucrase activity is probably due to the small oligosaccharides
produced by dextranase and/or by acceptor reactions. It was reported that
maltose and small dextrans can act as acceptors removing dextran from
enzyme active sites, increasing dextransucrase activity (138, 139, 152).
Total dextran yield ranged between 74 to 80 % of theoretical (Figure 15).
Theoretical yield is based on the total weight % of glucose available in
sucrose that can be added to a dextran chains. It is 48 % of the weight of
sucrose. At pH 5.4 the yield was the highest, 80 % of theoretical. Clinical
dextran was 90 to 93 % of the total dextran over the pH range 5.2 to 5.6. The
peak in LMW dextran corresponds to the peak pH activity range for both
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Comparison of activity of dextransucrase (open circle) and
dextranase (closed circle) at various pH's in mixed culture.
Enzyme activity unit; Ill/ml.
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%

Effect of pH on dextran productivity.
pH; ± 0.05, Total dextran (%) - Total dextran portion of
theoretical yield (open triangle, s.d.; < ± 2.0), Clinical dextran %
of total dextran produced were 93, 91, 90 and 78 % in pH 5.2,
5.4, 5.6 and 6.4. HMW - High molecular dextran (open circle, >
107 MW), LMW - Low molecular dextran (closed circle, clinical
dextran) - dextran which size ranged 75,000 ± 25,000.

enzymes in mixed culture. Based on total clinical dextran yields, a pH range
between 5.1 and 5.4 was selected for the mixed culture fermentations.

(3) Effect of temperature on the production of clinical dextran
Dextran yields were monitored as a function of growth temperature on
15 % sucrose fermentations (Figure 16). The total dextran yield was the
highest at 26 °C. The highest production of clinical dextran was at 29 °C,
where 92 % of the total dextran was clinical dextran. The doubling time of L
mesenteroides did not change between 26 and 29 °C (Table 7). However,
the doubling time for L. starkevi decreased 48 % between 26 and 29 °C,
then stabilized. It has been reported that at temperatures above 30°C,
dextransucrase is inactivated (43, 85, 159). The dextransucrase activity was
0.21 IU/108 cells (66 % of the activity at 26 ° C) at 32 °C. The mixed system
may act to stabilize this enzyme because of the presence of dextran. The
ATCC 74054 dextranase optimum temperature is near 55°C and it is very
stable below 30°C (Figure 9 & 10). A temperature of 28 (± 0.5) °C was
chosen as the optimum working temperature for the mixed fermentation
process.

(4) Sucrose concentrations
Because of the high levels of sucrose required in this fermentation,
the method of sucrose addition must be considered, i.e. discontinuous or
single addition. Discontinuous addition is the addition of the carbon source
in segments such that the total available carbon in the fermentor is always
portion of the total. The relative advantages for discontinuous vs single
sucrose addition were determined by measuring yields at 15 and 30 %
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Figure 16.

Effect of fermentation temperature on dextran yields.
Temperature; ± 0.5°C, Total dextran % of theoretical yield;
(open circle, ± 2.0), Clinical dextran % of total dextran
produced; (closed circle, ± 1.5), Clinical dextran % of
theoretical yield (open square).
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Table 7.
Temperature effect on the cell growth in mixed culture

Growth Temperature
26°C

29°C

32°C

L. mesenteroides

9.3

9.6

12.8

L. starkevi

28.8

14.7

13.5

o.32

0.29

0.21

Doubling Time (hr)

Specific activity of
dextransucrase

* Dextransucrase specific activity (IU/10® L. mesenteroides cells)
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Table 8.
The effect of discontinuous and single sucrose addition on dextran
productivity

Sucrose Concentration
15 %

30%

Discontinuous Single

Discontinuous

Single

Total

72.5

83.0

85.6

84.5

Dextran (%)

(± 2.1)1

(± 1.1)

(± 2.1)

(± 0.9)

Clinical*

68.2

65.6

80.5

61.7

Dextran Yield

(± 1-4)

(± 1.5)

(± 2.8)

(± 1.5)

Lm/Ls

50.8

305.9

22.2

100.0

Ratio

(± 1.6)

(± 15.6)

(± 1.3)

(± 2.2)

94

79

94

73

Clinical
Dextran (%)

* Clinical dextran yield % of theoretical dextran production, 1.Standard deviation

sucrose (Table 8). Based on total yield, a single addition was better than
discontinuous additions for 15 % sucrose level. However, the clinical
dextran portion was higher using discontinuous (94 %) rather than a single
addition (79 %). At 15 % sucrose the clinical dextran yield was 68.2 % (w/w)
for discontinuous addition versus 65.6 % (w/w) for single step addition. For
30 % sucrose the total dextran yield by discontinuous addition was similar to
that of a single addition, 85.6 % versus 84.5 %, respectively. The advantage
of discontinuous addition is obvious for clinical dextran production. Clinical
dextran yields were 80.5 % (w/w) for discontinuous and 61.7 % for a single
addition. This correlated with the growth ratio of L. mesenteroides to L.
starkevi. The growth ratios for discontinuous addition was about 51 /1 for 15
% sucrose and 22 /1 for 30 % sucrose. The single addition showed about
300 / 1 ratio for 15 % sucrose and as 100/1 for 30 % sucrose of JL.
mesenteroides to L. starkevi. Balanced cell growth is necessary to obtain
high yields of clinical dextran. The additional dextran obtained from the
second 15 % sucrose on a 30 % fermentation was almost 100 % of
theoretical yield. Little of the extra sucrose was used for cell growth.
Discontinuous addition is favored if high levels of sucroses are used. Total
and clinical dextran yields were independent of inoculum ratios of L^.
mesenteroides / L. starkevi. as long as they were at least 1 : 1 (up to 48 : 1)
(83). The cells stabilized at a ratio around 25 : 1 after initial sucrose
consumed.
Dextran yield depend on the total amount of sucrose (Figure 17). As
sucrose concentration increases from 15 to 30 %, the clinical dextran yield
increases. With high levels of sucrose a small portion of the sucrose will be
required for cell growth. Growth does not increase proportionally to the
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Sucrose Concentration (%)

Figure 17.

%

Clinical dextran productivity as a function of sucrose
concentration.
Open circle; Clinical dextran % of theoretical, Closed circle;
Specific productivity (gram of clinical dextran / 108 L
mesenteroides and L starkevi cells).

sucrose increase (Figure 17). The specific productivity varied from 1.45 gram
/108 cells to 3.80 gram /108 cells as sucrose varied from 15 to 30 %.
When the initial sucrose is consumed, L. starkevi cell numbers are
about 2 x 106 cfu / ml (Table 9), and L. mesenteroides cell numbers are
about 4 x 107 cfu / ml. Final cell numbers in 15 % sucrose fermentation were
7.9 x 108 cfu / ml Leuconostoc and 2 x 107 cfu / ml Lipomvces. As higher
sucrose levels are used L. mesenteroides cell number retained about the
same, however, some increase was seen in L. starkevi cell numbers. When
growth stopped the cell number ratios of L. mesenteroides to

starkevi

ranged from 20 to 40.
A comparison of dextransucrase activities at various sucrose
concentrations is shown in Figure 18. The dextransucrase activities (lU/ml)
were highest in 20 % sucrose fermentations. Dextransucrase activities at 25
and 30 % were lower than the values at 15 and 20 %, however, the
dextransucrase specific activity increased as sucrose concentration
increased.

IV. Mixed culture fermentation

The proposed optimized mixed culture fermentation process is as
follows. The first step is the the co-inoculation of L. starkevi ATCC 74054 and
L. mesenteroides ATCC 10830 into the production vessel. L. starkevi ATCC
74054 and L. mesenteroides ATCC 10830 seed cultures are grown
separately on LW media containing 2 %(w/v) sucrose. The dextran polymers
are not visible in the Leuconostoc culture at this stage except as viscous
material which surrounds the cell (Figure 19). L. starkevi ATCC 74054

82

Table 9.
Effect of the final sucrose concentration on final L. mesenteroides and L
starkevi cell numbers

Sucrose
(%)*

L. mesenteroides

L. starkevi

Lm#/Ls#

cfu/ml (x 107)

cfu/ml (x 107)

Ratio

3

4

0.2

20.0

15

79

2.0

39.5

20

71

2.1

33.8

25

66

2.3

28.7

30

64

3.0

21.3

* Fermentation time (hours); 3 % - Initial sucrose, Samples were taken at the end of
fermentations where 12.5, 32, 36, 49 and 52 hrs, respectively, Lm #; L. mesenteroides cell
number (s.d. : ± 5 x 107), Ls #; L. starkevi cell number (s.d.: ± 4 x 106).
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Dextransucrase productivity as a function of sucrose
concentration.
Samples were taken at the end of the fermentation; for 15 and
20 % - at 32 and 36 hours, for 25 and 30 % - at 49 and 52
hours, Dextransucrase activity (open circle), Specific activity IU/108 cells (closed circle), Initial sucrose concentration was 3
% in LW 3 medium.
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Figure 19.

SEM micrographs of L. mesenteroides ATCC 10830.
(A) Grown in LW medium containing 2 % sucrose, ruthenium
red treated (x 17,200), bar = 1 urn, (B) Grown in LW medium
containing 10 % sucrose, ruthenium red treated (x 6,450), bar
= 5 f-im.
The specimen was coated with gold-palladium in the hummer
sputter coater then it was viewed on the JOEL 100CX SEM (A)
or on the Cambridge Stereoscan 260 SEM (B) at 15 KV.
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shows no evidence of any polymer in the inoculum (Figure 20). The
inoculation volume is 1.5 % (v/v) at a rate 0.3 % (v/v) L. mesenteroides to 1.2
%(v/v) L. starkevi. The pH is controlled at 5.2, and the temperature is
controlled at 28 °C. Aeration is required at 1.0 wm for L. starkevi growth and
agitation is 100 rpm.
For efficient enzyme production and control of dextran synthesis,
discontinuous sucrose addition is favored. Based on final volumes for a 30
% sucrose fermentation, the starting level of sucrose is 3 %(w/v). After 12
hours 9.5 % of the sucrose is added and then after a further 9 hours, the
remainder (16.5 % or 9.5 % and 7 % in batches) is added. The fermentation
is then allowed to proceed to completion; between 20 and 40 hours after the
final sucrose addition. After 12 hours from inoculation, the cell number ratio
is 24 to 1 (L. mesenteroides to L. starkevi). The dextran size distribution
changes with time are shown in Figure 21 and 22. Initially, medium size
(M.W. 150,000 - 1,000,000) dextrans are produced. With increasing time, the
amount of medium size dextran decreases and the amount of clinical
dextran increases. The increase of medium size dextrans seen at 30 hours
is a result of the sucrose addition at 21 hours. When 20 to 30 % sucrose is
used to produce clinical dextran, the fermentation takes between 30 and 60
hours to complete. Micrographs of the mixed culture at 21 hours are shown
in Figure 23. The dextran polymers, except for some thread-like material, are
not visible without specific staining. These thread-like materials may be high
molecular weight dextrans (Figure 24). Many bud scars were visible on the
L. starkevi indicating the growing state of the culture. With ruthenium red
treatment dextran polymers were visible (Figure 23 B). Half of the dextran is
clinical size dextran at this point (Figure 21 and 22). When the fermentation
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Figure 20.

SEM micrographs of L. starkeyi ATCC 74054 (grown in LW
medium containing 2 % sucrose).
(A) Without Ruthenium red treatment (x 13,000), bar = 1 nm,
(B) Ruthenium red treated (x 9,650), bar = 1 ^m.
The specimen was coated with gold-palladium in the hummer
sputter coater then it was viewed on the JOEL 100CX SEM (A)
or on the Cambridge Stereoscan 260 SEM (B) at 15 KV.
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Figure 21.

GPC chromatograms of dextrans from a 30 % sucrose mixed
culture fermentation.
(A) 12 hours, (B) 21 hours, (C) 50 hours. The solid line shows
size of polymers and the broken lines show dextran
concentrations. Intergration was done using a DAWN GPC
detector. Size decreases with increasing volume.
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Figure 22.

Dextran distribution with time.
Final sucrose concentration was 30 %, M.W. of LMW, MMW
and HMW are less than 150,000, between 150, 000 and 106,
and greater than 10®, respectively.

92

Figure 23.

SEM micrographs of L. starkevi and L. mesenteroides in mixed
culture.
(A) Without Ruthenium red treatment (sample at 21 hours after
inoculation),1; Photographed at a magnification of 2,150 x, bar
= 5 urn, 2; Photographed at a magnification of 7,820 x, bar = 1
nm. No dextran visible except some thread-like materials.
(B) Ruthenium red treated (samples at 21 hours after
inoculation), Photographed at a magnification of 3,940 x, bar =
4 urn. Dextrans are visible.
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Figure 24.

SEM micrographs of pure and mixed culture.
(A) Micrograph of L. mesenteroides grown on 4 % sucrose for
24 hours, without Ruthenium red treated, Photographed at a
magnification of 9,190 x, bar = 2 jim.
(B) Micrograph of mixed culture grown on 26 % sucrose for 15
hours, Ruthenium red treated, Photographed at a
magnification of 4,490 x, bar = 4 urn.
Arrows indicate the thread-like materials.
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is stopped more than 90 % of the dextran was clinical size dextran (Figure
25). Figure 26 shows the mixed culture sample at this point. Changes in
glucose, fructose, leucrose, mannitol and higher oligosaccharides during
fermentation are shown in Figure 27. At the end of fermentation remaining
fructose was about 9 % (w/v), both leucrose and mannitol were 2 % (w/v)
and glucose and higher oligosaccharides were less than 1 % (w/v).
It was possible to distinguish between high molecular weight dextran
and low molecular weight dextran using ruthenium red staining. Figure 19 B
shows a Leuconostoc pure culture containing high molecular weight dextran
(4 %). The dextran showed a net like structure. Most dextran had greater
than 107 M.W. (Figure 25). In contrast, the dextran polymers seen in the
mixed cultures were smooth (Figure 26). Although L. mesenteroides cells
were surrounded by net like dextran in the mixed culture, the degree of net
structure was less than in L. mesenteroides pure cultures.

V. Product characterization

(1) Viscosity comparisons of products
Viscosity of the product varied depending on the

dextran

concentration and size distribution (Table 10). A standard T 40 solution has
a lower viscosity than equivalent weights of industrial grade dextran (M.W.
5,000,000 to 40,000,000, Sigma Chemical Co.) material. Clinical dextran
(M.W. 20,000) has also a low viscosity. It has a 50 fold lower viscosity than
high molecular weight dextran produced by L. mesenteroides pure culture.
Because of lowered viscosities observed in mixed culture permit pH and
temperature to be controlled more efficiently. The substrate distribution
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Figure 25.

Cumulative dextran molecular weight distributions.
Molecular weight distributions were obtained using EASI
program after processing GPC data with ASTRA ™ software.
A; Mixed culture dextran, B; pure culture dextran.
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Figure 26.

SEM micrographs of L. starkevi and L. mesenteroides in mixed
culture.
Ruthenium red treated (samples at 50 hours after inoculation),
(A) ;Photographed at a magnification of 1,250 x, bar = 20 jim,
(B) ;Photographed at a magnification of 3,230 x, bar = 10 ^m.
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Sugar changes during mixed culture fermentation.
LW 3 medium containg 30 % sucrose was used. Open circle;
glucose, closed circle; fructose, closed square;
isomaltooligosaccharides, open square; leucrose, closed
triangle; mannitol.
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Table 10.
Viscosity comparisons of products

Dextrans (5 % w/v)
Industrial grade dextran

Viscosity (cps)
48.7

Dextran T 40

1.3

Dextran T 500

2.6

Mixed culture dextran

1.2

L. mesenteroides culture dextran

58.5

•Industrial grade dextran (Sigma Chemical Co., M.W. 5,000,000 to 40,000,000), T 40 K
(Sigma Chemical Co., M.W. 35,600), T 500 K (Sigma Chemical Co., M.W. 507,000), Mixed
culture fermentation dextran (M.W. 20,000), L. mesenteroides pure culture dextran (M.W.
over 4 x 107), *" Viscosity; unit; Centipoise (mPa.s)
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within the fermentor probably is also better. Moreover, higher sucrose
concentrations (over 30 %) can be used giving higher yield.
(2) A comparison of clinical dextran yield as a function of sucrose
concentration in mixed culture
Comparisons of the yields of dextran produced by mixed and pure
cultures are shown in Table 11 for 15 and 30 % sucrose. Total yields were
similar for both fermentations. At 15 % sucrose, pure culture produced 78 %
of the theoretical dextran and mixed culture produced 74 %. At 30 % sucrose
pure culture produced 72 % of theoretical and mixed culture produced 87 %.
The average M.W. of dextrans from 15 % pure culture was 2.2 x 107.
Production of clinical dextran by hydrolysis normally yields about 66 % of
theoretical (based on 85 % clinical dextran recovery after acid hydrolysis
and alcohol fractionation). The yield of clinical dextran for the mixed culture
(15 %) was 68.8 %. With the 30 % sucrose fermentation the yield differences
become apparent. Clinical dextran can be produced at 66 % and 61 % of
theoretical yield from 15 and 30 % pure cultures, respectively (Dr. Patel,
Chemdex Inc., FL, personal communication). The mixed culture (with
discontinuous addition) yielded 84 % of theoretical. The

average

polydispersity index of the product of mixed fermentation was between 1.2
and 1.5. Commercial clinical dextran has a polydispersity index of 1.5 to 2.0.

VI. Mechanism of clinical dextran formation

(1) Maltose and dextran addition
Surprisingly, in the supernatants of mixed culture fermentations
significant amounts of isomaltose, isomaltotriose and other small
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Table 11.
Dextran yields with pure and mixed culture

Yield (% of theoretical)
Type-

Pure-15%

Mixed-15%

Pure - 30 %

Mixed - 30 %

78

74

72

87

appr. 66*

68.8

appr. 61*

84

Sucrose %
Total Dextran
Clinical
Dextran

Mixed- Mixed fermentation with discontinuous sucrose addition, 3 % initial sucrose, Pure - L
mesenteroides pure culture fermentation, 15 and 30 - sucrose concentration (%), Total
dextran yield; % of theoretical - w/v (± 2.0), Clinical dextran yield; % of theoretical - w/v, *
Expected value based on 85 % clinical dextran recovery after acid hydrolysis and alcohol
fractionation, Yield was calculated by GPC assay.
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isomaltooligosaccharides (or small dextran hydrolyzates) were not detected
(Figure 28). In L. mesenteroides pure culture supernatants significant
amounts of oligosaccharides in addition to fructose were detected. To test for
isomaltose and isooligosaccharide incorporation into dextran, maltose (3 %w/v) was added to Leuconostoc fermentations (12 % sucrose) when the
sucrose level was 9 %. It has been reported that maltose and isomaltose are
good acceptors with similar efficiencies (32, 155). Molecular weight
distributions after the addition of maltose are shown in Figure 29. Prior to the
addition of maltose to the L. mesenteroides culture, high molecular weight
dextran (molecular weight greater than 10 million) composed greater than
90 % of the product. Most of the dextran was of molecular weight 1.3 x 107
(Dextran A), however, there was a small second fraction of 4.3 x 106
(Dextran B) (Table 12). After the addition of maltose, smaller size dextrans
were detected in increasing amounts with time. The average molecular
weight of each fraction decreased by 1/2 after 5 hours. A further 20 %
decrease in molecular weight was observed in Dextran B in the next 5
hours. Before the addition of maltose the mass ratio of large to small dextran
was 16.2. After the addition of maltose the ratio decreased to 4.3 after 10
hours.
Dextransucrase specific activity decreased with time after the addition
of maltose (Figure 30). However the activity 5 hours after the addition of
maltose was higher than that observed in the control.

After 10 hours, the

dextransucrase levels were similar. It has been reported that maltose
addition stimulates the dextransucrase activity over a short period by the
removing of dextran from the active sites (138, 139, 152).
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Figure 28.

Thin layer chromatogram of supernatants from mixed culture
and pure culture fermentations.
Supernatants of mixed culture (20 % sucrose) (A) and pure
culture (20 % sucrose) (B) were loaded on Thin-Layer
chromatogram on Whatman K5 0.25 mm silica gel in solvent C;
detection by 20 % sulfuric acid in methanol; Mixed Culture
Supernatants, G; Glucose, F; Fructose, S; Sucrose, P; Panose,
IMn; Isomaltooligosaccharides, 1,2,3; supernatant at 12, 15
and 21 hrs, respectively, 4,5,6; supernatants at 28, 32, and 40
hrs, respectively ; Leuconostoc mesenteroides Culture
Supernatants, 5-7; Dilution of 2 - 4 supernatants at 24, 32,
and 40 hrs, respectively.
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Figure 29.

Cumulative dextran molecular weight distribution after the
addition of maltose. Molecular weight distributions were
obtained using EASI program after processing GPC data with
ASTRA™ software.
12 % sucrose L. mesenteroides pure culture in LW medium,
(A) Before the addition of maltose (3 %), (B) 5 hours after the
addition of maltose, (C) 10 hours after the addition of maltose.
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Table 12.
Effect of maltose addition on dextran size distribution

Time
(hrs)

Dextran A
% (w/v)
M.W.*
(X 106)

Dextran B
% (w/v)
M.W.*
(x 106)

Control
M.W.*
(x 106)

0

13

2.10
(±0.10)

4.3

0.13
(±0.01)

13

5

12.6

6.60
(±0.21)

2.1

1.33
(±0.09)

21

10

12.4

6.91
(±0.17)

1.6

1.61
(±0.03)

30

* M.W. ; (x 106, < ± 2x 105), Time; Time passed after the addition of maltose, Dextran A;
Dextran of M.W.> 107, Dextran B; Dextran of M.W. <107, Control; L. mesenteroides pure
culture on 15 % sucrose, 0; Before the addition of maltose, 5; After 5 hours from maltose
addition, 10; After 10 hours from the addition of maltose (3 %), At 0 hour and control, there
were two fractions, dextran A and Dextran B. At 5 and 10 hours, there was only one fraction,
Dextran A, in control.
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Figure 30.

Effect of maltose addition on dextransucrase activity in the
L. mesenteroides pure culture.
Dextransucrase activity (lU/mg L. mesenteroides). 0; Before the
addition of maltose, 5; After 5 hours from maltose addition, 10;
After 10 hours from the addition of maltose, open circle;
dextransucrase activity after maltose addition, closed triangle;
dextransucrase activity of control pure culture.
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Isomaltose is an end product of dextranase action. Maltose mimics
the action of isomaltose. To test the possible maltose incorporation into
dextran, two sets of cultures were prepared. A Leuconostoc pure culture
fermentation containing various maltose concentrations in addition to
sucrose and a mixed culture containing starch in addition to sucrose. Starch
was used in mixed culture because the L. starkevi will produce amylase,
producing maltose, rather than utilizing maltose for growth (Table 3). The
molecular weight of the dextran from maltose containing pure culture
fermentations was 4,000. The molecular weight of dextran from starch
containing mixed culture was about 40,000. Acid and dextranase
hydrolyzates of the dextrans are shown in Figure 31. Panose (a-D-Glc(1-6)a-D-Glu(1-4)-D-Glu) is seen in hydrolysates from both fermentations as well
as

isomaltose

and

isomaltooligosaccharides.

Maltose

and

maltooligosaccharides were incorporated in dextran from the starch
containing mixed culture fermentations because ATCC 74054 produces
amylase. Amylase hydrolysates were incorporated into the dextran.
Therefore it is probable that dextran hydrolysates, isomaltose or
isomaltooligosaccharides, may also be incorporated into the dextran in
mixed culture acting as acceptors for clinical dextran. This would explain the
absence of small isomaltooligosaccharides in the mixed

culture

supernatants.
Exogenous dextran (larger or low molecular weight dextran) was
added to L. mesenteroides fermentations and dextransucrase activities were
compared (Table 13). The addition of larger size dextran (1.15 x 106 M.W.,
LD) to the fermentation decreased growth of Leuconostoc. Dextransucrase
activity doubled upon addition of LD dextran. The change in molecular
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Figure 31.

Acid and enzyme hydrolysates of dextrans (or polymers).
Acid and enzyme hydrolysates of dextrans (or polymers) from
maltose containing L. mesenteroides pure culture (A) and
starch containing mixed culture (B). Thin layer chromatogram
on Whatman K5 0.25 mm silica gel in solution A; detection by
20 % sulfuric acid in methanol, G; Glucose, P; Panose, IM2;
Isomaltose, M2; Maltose, M3; Maltotriose and IMn;
Isomaltooligosaccharides, (A)Partial acid hydrolysis of dextran
produced by Leuconostoc mesenteroides on maltose (5%) and
sucrose(10%) 1 - 5; Acid partial hydrolysis; 20, 30, 40, 60 and
90 min, respectively, 6-10; Dextranase partial hydrolysis using
ATCC 74054 dextranase (0.5 lU/ml); 30, 45, 60, 90 and 120
min, respectively, (B) Acid and dextranase partial hydrolysis of
dextran from mixed culture on soluble starch(3%) and
sucrose(12%)1 - 4; Acid partial hydrolysis; 30, 40, 60 and 90
min, respectively, 5 - 8; Dextranase partial hydrolysis using
ATCC 74054 dextranase (0.5 lU/ml); 30, 45, 60 and 90 min,
respectively.
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Table 13.
Effect of dextran addition on L. mesenteroides pure culture fermentations

Cell Mass

Dextransucrase specific

(mg/ml)

activity (lU/mg)

Control

2.9

0.04

LMW dextran

2.8

0.04

LD dextran

2.2

0.08

Type

* Cell mass : cell dry weight - mg/ml, < ± 0.1, ** Dextransucrase : lU/mg at the end of
termentation (about 24 hours from start), < ± 0.01, *** Control; L. mesenteroides pure culture
on 15 % sucrose, LD; Larger size dextran (average 1.15 x 106). LMW ; Low molecular weight
(average M.W. of 40,000), Dextran was added after 12 hours from start.
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weight distributions after the addition of dextran is shown in Figure 32. After
the addition of LD dextran, the molecular weight distribution shifted toward
smaller sized dextrans. Without the addition of exogenous LD dextran, the
dextran size distribution was typical of a L. mesenteroides pure culture. After
the addition of exogenous dextran, the product size distribution shifted
toward smaller size dextrans, emphasizing the need for acceptors for
controlling dextran size.

(2) Effect of dextranase on dextran size in L. mesenteroides pure
culture
The effect of the dextranase addition to L. mesenteroides pure culture
was also examined. ATCC 74054 dextranase (0.5 lU/ml) was added to a
Leuconostoc fermentation and dextran size was monitered with time (Table
14). Two hours after the addition of dextranase, the average

molecular

weight of the larger fraction was essentially unchanged. However, as with
dextranase addition, size decreased significantly compared to the control.
The average molecular weight of the smaller fraction decreased from 1.3 x
106 to 0.8 x 106 after 20 hours. The mass ratio of larger fraction to smaller
fraction changed from 14.9 to 0.36 after 20 hours.
The dextransucrase activity increased from 1.18 to 1.42 (lU/mg) after
two hours, but after 20 hours, dextransucrase activity decreased to 0.08
lU/mg cells (Figure 33). The dextransucrase activity increase (2 hours post
dextranase addition) may be caused by dextranase removal of the dextran
from the dextransucrase active sites (138, 139, 152). The control value for
dextransucrase, 20 hours post dextranase addition, was 0.09 lU/mg.
Dextranase had no effect on the stability of dextransucrase.
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Figure 32.

Cumulative dextran molecular weight distributions after the
addition of exogenous dextrans.
Molecular weight distributions were obtained using EASI
program after processing GPC data with ASTRA™ software.
Comparison among LD (1.15 x 106 m.W. dextran 1 %-w/v),
LMW dextran additions (M.W. 40,000 dextran, 1 %) and without
(N) addition of exogenous dextran.
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Table 14.
Effect of dextranase addition on L. mesenteroides pure culture

Dextran A

Dextran B

Control

Time
(hrs)

M.W.*
(x 106)

% (w/v)

M.W.*
(x 106)

% (w/v)

M.W.*
(x 106)

0

13.3

1.79
(±0.10)

1.3

0.12
(±0.03)

13

2

16.8

0.93
(±0.12)

1.2

1.80
(±0.05)

22

20

15.4

1.51
(±0.11)

0.8

4.25
(±0.02)

33

* M.W. ; (x 10®, < ± 2x 105), Time; Time passed after the addition of maltose, Dextran A;
Dextran of M.W.> 107, Dextran B; Dextran of M.W. <107, Control; L. mesenteroides pure
culture on 15 % sucrose, 0; Before the addition of dextranase (18 hours from fermentation
start), 2; After 2 hours from dextranase addition, 20; After 20 hours from the addition of
dextranase.
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Figure 33.

Effect of dextranase addition on dextransucrase activity in
theL. mesenteroides pure culture.
Dextransucrase activity (lU/mg L. mesenteroides). 0; Before the
addition of dextranase (18 hours from fermentation start), 2;
After 2 hours from dextranase addition, 20; After 20 hours from
the addition of dextranase, open circle; dextransucrase activity
after dextranasee addition, closed triangle; dextransucrase
activity of control pure culture.
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At the end of pure culture fermentations (20 % sucrose) dextranase
was added and changes in dextran polymer size and amounts were
examined (Figure 34). Before the addition of dextranase, dextran size was
greater than 10 million M.W. and the yields were 76 % of theoretical. After
the addition of dextranase, both dextran size and amounts changed. The 10
million size dextran was degraded to smaller dextrans. After 4 hours, the
amount of isopropanol (67 %-v/v) precipitable dextran had decreased to
23.3 % of theoretical or 30.6 % of original dextran in the culture. After 6
hours, the differences due to dextranase addition was even clearer, 8.8 % of
the theoretical yield of dextran was precipitated, or

11.6 % of the initial

dextran was recovered. Although the dextran size decreased, no significant
amount of clinical dextran was produced. Dextranase addition during
fermentations, which had residual sucrose (8 %), resulted in different
dextran sizes and amounts (Figure 35). The high molecular size dextran
portion did not change. Clinical dextran was produced, and it consisted of
about 23 % of the total precipitable dextran. The total precipitable dextran
was 27.6 % of theoretical. This compares to the 8.8 % for total dextran yield
when sucrose was absent. When sucrose was present, only a small amount
of isomaltooligosaccharide was detected. When a sucrose was depleted, the
amount of isomaltooligosaccharides increased sharply (Figure 36). In the
presence of sucrose, isomaltose and isomaltooligosaccharides can act as
acceptors for smaller size dextrans. When the sucrose is absence, the
concentration of isomaltooligosaccharides increases due to dextran
cleavage.
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Figure 34.

Effect of dexranase addition on fermentations containing
no residual sucrose.
Time (hr); Time passed after the addition of dextranase (0.3
lU/ml), 0; 36 hours from fermentation start, Distribution (%) of
the total dextran, LW 3 medium, pH 5.2 control, temperature 30
°C control.
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Figure 35.

Effect of dextranase addition on fermentations containing
residual sucrose.
Time (hr); Time passed after the addition of dextranse (0.3
lU/ml), 0; 21 hours from fermentation start - 8 % residual
sucrose, 20 hours is similar period of fermentation at 6 hours
of Figure 34, at this time most sucrose has been used,
Values are the istribution (%) of the total dextran, LW 3
medium, pH 5.2 control, temperature 30 °C control.
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Figure 36.

Change in amount of sucrose and isomaltooiigosacharide with
time.
Open circle is residual sucrose % (w/v) and closed circle is
isomalto oligosaccharide % (w/v) in culture. LW 3 medium, pH
5.2 control, temperature 30 °C control
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VII. Product recovery

(1) Alcohol precipitation
Dextran is fractionated commercially by alcohol precipitation with
either ethanol or isopropanol. Dextran precipitation efficiency with
isopropanol is related to dextran size (Figure 37). High molecular weight
dextran precipitates at low concentrations of isopropanol. Above 106 M.W.
dextrans from mixed cultures precipitate with 40 % (v/v) isopropanol.
Smaller size dextrans require up to 67 % (v/v) isopropanol. With 60 %
isopropanol most dextran greater than 104 precipitates. High and low
molecular weight dextrans can be separated by alcohol fractionation.
The size distributions of precipitated dextrans by isopropanol and
ethanol (95 %) are shown in Table 15. An increase in ethanol concentration
(from 40 % to 55 % - v/v) resulted in increased precipitation of dextrans of
the size range 5 x "lO^o 105. When ethanol concentration is increased to 67
% (v/v), dextrans smaller than 104 M.W. precipitated. An increase in
isopropanol concentration from 40 to 55 % increased the precipitation of
dextran of sizes 10^0 5 x 104. Isopropanol (67 %) precipitated smaller size
(less than 104 M.W.) dextrans. The amount of dextran precipitated at
different alcohol concentrations were comparable for both alcohols. At the
same concentration isopropanol was more efficient than ethanol in total and
clinical dextran recovery.

(2) Salt effects on solvent precipitation
The addition of KH2PO4 and/or MgS04 to the samples increased the
recovery of dextran on alcohol precipitation (Table 16). At 67 % ethanol,
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Figure 37.

The precipitation pattern of mixed culture dextrans by
isopropanol.
Dextran precipitation with various concentrations of
isopropanol, ** M.W. of 20 % of sample dextran was 10,000,
70 % was 30,000 and 10 % was greater than 5 x 106. y - axis is
the cumulative % of dextran recovered.

125

Table 15.
Comparison of dextran recoveries by ethanol or isopropanol precipitation

Size of Product
Alcohol
(%-v/v)

Recovery >5 x 10£

> 105-

> 5 x 104

> 1Ql

> 5 x 103.

(%V
Ethanol

40

8

10"

8

8

72

0

55

51

6

6

16

72

0

67

80

6

2

2

52

38

Isopropanol
40

14

7

5

10

78

0

55

63

7

5

4

84

0

67

83

4

5

3

24

64

' Total Recovery (%); (Precipitated dextran amount/ Original dextran amount) x 100, *' % of
Total Recovered; Data were re-organized from GPC and EASI analyses, and data are % of
precipitated dextran at each alcohol concentration, Sample was prepared from mixed culture
fermentation
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Table 16.
Effect of salts on dextran precipitation by ethanol

Relative Recovery of Dextran (%)
Dextran*

A

B

C

D

E

I

94.1

96.8

100"

97.2

92.5

II

95.9

97

98.9

100

94.6

III

92.7

97.6

100

99.7

89.2

*l - Industrial grade dextran (Sigma Chemical Co.): 5%, II - T 2000 (Pharmacia Co.): 10 %, III Mixed culture fermentation sample (approximate M.W. - 40,000) : 10 %, Solvent - 95%
ethanol, final solvent concentration was about 67%, ** 100 % means the highest recovery of
each dextran sample , Those values were obtained by saccarimeter, A; 0.4 % KH2PO4 and
0.05 % MgS04l B; 0.4 % KH2P04 and 0.1 % MgS04l C; 0.4 % KH2P04 and 0.15 %
MgS04, D; 0.4 % KH2P04 and 0.18 % MgS04l and E;Control - No salt addition.
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salts are not precipitated. At the equivalent ethanol concentration, salt
containing sample precipitated better than controls. An examination of the
effect of salt concentrations on isopropanol, ethanol and methanol
precipitation are shown in Table 17. With methanol, 77 % of the dextran was
recovered without salt addition. Recovery increased upon the addition of
KH2PO4. Ethanol precipitation produced greater recovery of dextran upon
the addition of KH2PO4 and MgS04. Isopropanol recovery was better than
methanol without or with MgSCU.
It is reported that neutral hydrolysates of a 5 % commercial dextran
solution contain approximately 2 % sodium chloride (200). The effect of the
addition of NaCI and MgSC>4 upon dextran recovery are compared in Table
18. MgSC>4 addition increased recovery about 2 % with isopropanol
precipitation over NaCI addition. Since acid hydrolysis and neutralization
steps are not required for mixed culture fermentation, the addition of salt can
be considered to increase dextran recovery (i.e. 0.36 % MgSC>4 in case of
isopropanol precipitation).

VIII. Protein (residual dextranase) removal

Dextran samples from mixed culture fermentations contain less than 2
ng per ml protein in 10 % dextran solutions. However, residual dextranase
activity was present in the samples. A 10 % dextran solution (dextran was
vacuum dried at 30 °C) kept at room temperature 4 days showed
degradation (Table 19). Without acid treatment, after 4 days of incubation,
dextran size decreased. However, by dropping the pH to 1.7 with acid,
changes in dextran size were stopped. Since during industrial production,
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Table 17.
Effect of salts on dextran precipitation by methanol, ethanol or isopropanol

% Recovery*
Salt Ratio

Isopropanol

Ethanol

Methanol

A

83

85

85

B

88

87

82

C

83

91

84

D

83

85

77

* % recovery; Recovered dextran (%) of original dextran, ** Ethanol - 200 proofs, The values
were % of initial dextran concentration and were measured by Saccharimeter and, Dextran
used is T40 (Pharmacia, Sweden) : 5 % solution, pH 5.6, Solvent concentration was 53 %,
Data were obtained after twice solvent precipitation of T40 dextran. A; 0.36 % KH2PO4, B;
0.36 % MgS04, C; 0.18 % KH2PO4 and 0.18 % MgS04, D;Control - No salt addition.
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Table 18.
Effect of NaCI or MgS04 addition on dextran recovery

Salt (% - w/v)

Recovery (% of original dextran)

NaCI (1 %)

86 (± 0.2)

NaCI (2 %)

86 (± 0.3)

MgS04 (0.36 %)

88 (± 0.3)

* Control dextran sample was 5 % T150 (average M.W. of 150,000; kindly supplied by Dr.
Patel, Chemdex Inc.), Isopropanol 67 % was used and decantation was done for 24 hours at
room temperature.
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Table 19.
Effect of residual dextranase activity on dextran prepared from mixed culture

Mass Ratio

Size Ratio of Clinical

(Control1 fTreatment2)

Dextran3 (C1/T2)

HCI addition (pH 1.7)

1.0

1.0

No HCI addition (pH 5.5)

1.0

1.4

1. Control - The amount of dextran before incubation at 30°C, 2. Treatment (T) - The amount
of dextran after incubation at 30°C for 4 days, 3. Clinical Dextran - Low molecular weight
dextran in sample (average M.W. of 32,000).
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dextran solutions are heated to remove solvent, dextranase should be
inactivated during practical process.
Commercial practice uses activated charcoal to remove color from
dextran solutions (Dr. Patel, personal communication). To determine
whether the residual dextranase (protein) can be removed by activated
charcoal, a 10 % (w/v) dextran solution of average M.W. 500,000 was mixed
with crude ATCC 74054 dextranase and filtered through an activated
charcoal column (150 x 15 mm). The column removed 31.5 % (16.3 mg/ml)
of protein (Table 20). A heated sample was also filtered through this column.
The removal of protein from this sample was lower; 26.1 % (13.6 mg/ml).
After acid treatment removal increased to 71.4 % (37.1 mg/ml). It is possible
that pH changes the protein charges and improves its binding to activated
charcoal. A filtered dextran sample, without heat inactivation, was found to
undergo no change in size after 7 days.
It is known that dextranase binds to different size dextrans with
different affinities (93). The ability of the activated charcoal to remove
dextranase was dependent on the size of the dextran in mixed with the
protein. Only 16.4 % mixed with T2000 was removed, whereas 36.5 % of the
protein mixed with T40 dextran was removed. Since mixed culture broth
contains smaller size dextran, the residual protein (or dextranase) probably
can be easily removed.

IX. Identification of HMW dextran present in mixed fermentations

A small proportion of high molecular weight polymer is always found
in the mixed culture process. To eliminate the possibility that this material is
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Table 20.
Dextranase removal using activated charcoal

Treatment*

Protein (%) remained

Protein (%) removed

Enzyme**

100

0

Active sample

68.5

31.5

Heat inactived sample

73.9

26.1

Acid inactived sample

28.6

71.4

Active T2000 sample

83.6

16.4

Active T 500 sample

68.5

31.5

Active T40 sample

63.7

36.5

* Preparations of dextran and dextranase mixture with various treatments, ** Enzyme - ATCC
74054 Dextranase concentrate from sucrose grown (520 mg/ml & 27 lU/ml), Active sample;
dextran T500 (10 %) solution containing ATCC 74054 dextranase (final 52mg/ml) and filtered
through activated charchol column, Remained and removed protein (%) - protein % remained
and removed after Alteration with activated charchol, Heat - Boiling for 5 min, Acid - Addition of
HCI to pH 1.7, 100 % means 52 mg/ml protein, T2000, T500 and T40; Dextrans M.W. of
2,000,000, 500,000 and 40,000, respectively, Active T2000 sample was active sample
containing T2000 (10 %) instead of T500.
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a polymer other than dextran, its composition was determined. Polymer was
acid hydrolyzed and analyzed (Table 21). The acid hydrolyzate contained
only glucose. The polymer was also treated with ATCC 74054 dextranase
concentrate (0.5 lU/ml). After hydrolysis 5.8 % of sample was unhydrolyzed.
This unhydrolyzed remaining material may consist of non a 1,6 linked
dextrans that are resistant to ATCC 74054 dextranase (endo-type). It has
been reported that L. mesenteroides NRRL B-512 produces 94 - 95 % a 1,6
linked dextran and 5 - 6 % a 1,3 linked dextrans, which is endo dextranase
resistant (187).
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Table 21.
Hydrolysis of mixed culture dextran with acid or dextranase

% of Total Carbohydrate
Type

Control

Glucose

Fructose

Isomaltooligo-

Residual

saccharide

dextran

0

0

0

100

Acid

100

0

0

0

Enzyme

12.3

0

81.9

5.8

Control dextran was prepared using 20 % sucrose, Acid hydrolysis was done tor 4 hours at
110 °C and enzyme hydrolysis was done with 0.5 Ill/ml ATCC 74054 dextranases for 2 days at
room temperature.

DISCUSSION
Low molecular weight dextrans have their largest application in the
pharmaceutical industry. Commercially, dextran is produced from sucrose
fermentations by Leuconostoc mesenteroides ATCC 10830. The bacteria
are grown in a medium containing 15 % (w/v) sucrose along with other
required nutrients. Native dextran has a molecular mass of about 5 x 108
daltons. This size is unsuitable as a blood plasma substitute. Relatively low
molecular weight dextrans (a few hundred to a million) are produced by
controlled acid hydrolysis of native dextran, followed by organic solvent
fractionation. The process has drawbacks. It requires multi-steps, i.e. alcohol
precipitation, acid hydrolysis, cooling, and neutralization. The yields are
relatively low due to losses during repeated fractionation and the inherent
viscosity of the fermentation because of the high levels of large polymers. A
new fermentation process was developed to overcome these limitations in
the production of clinical dextran. It involves use of a mixed culture
fermentation with a dextranase producing strain (Lipomvces starkevi) and a
dextransucrase producing strain (Leuconostoc mesenteroides).
The requirement of this process for the L. starkevi is an ability to
produce dextranase in the presence of fructose, which exists in high
concentrations in dextran fermentation broths. The organism of choice is a
mutant of L. starkevi ATCC 12659, an ascosporogenous yeast, which has
been used in food related applications and produces dextranase (82, 93). It
was selected after chemical mutagenesis (ethyl methane sulfonate) on
double layered plates containing blue dextran as a dextranase indicator.
The selected mutant, L. starkevi ATCC 74054, produces dextranase on all
carbon sources. Its specific dextranase productivity on dextran, 0.14 lU/mg
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cell, is as good or better than the dextranase productivity of the parental
type, 0.11 lU/mg cell. It produces dextranase on glucose, sucrose and/or
fructose. On soluble starch, ATCC 74054 produces 4 fold more dextranase
than on maltose, sucrose, glucose or fructose. It produces greater than 60 %
of the amount of enzyme produced on dextran. Different starches (soluble
starch vs corn starch) gave different dextranase productivities. The parental
strain does not produce dextranase when grown on starch. Dextranase
production in Lipomvces is an example of a repressible - inducible system
(99). However, ATCC 74054 is not only a derepressed but also a constitutive
mutant for dextranase production. It is possible that repression by glucose,
and dextranase inducibility in Lipomyces is controlled by different
mechanisms. Some Saccharomvces cerevisiae mutants produce maltase,
invertase, and/or galactokinase constitutively on galactose (6, 7, 201) or
raffinose (47, 48, 65, 201) in the presence of 2-deoxy-D-glucose. This
situation may be similar for Lipomyces.
Dextranase (group of dextranase isozyme) from ATCC 74054 has a
pH optimum of 5.5 and a temperature optimum of 55 °C. The optimum pH
value is lower than that of the dextranase from the parental strain, pH 6.5.
The thermal stability of the enzyme depended on the carbon source on
which it was produced. Dextranase produced by ATCC 74054 on fructose
had a higher thermal stability than the enzyme produced on dextran or
starch, or than the parental enzyme (82). The optimum pH and the higher
thermal stability make this strain useful for this mixed culture system. The
dextranase pH optimum is close to the optimum for dextransucrare and
highest stable pH of dextransucrase, pH 5.2 (5). At pH 5.2, dextranase
activity is over 90 % of that at pH 5.5. The dextran hydrolysis products of
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sucrose grown ATCC 74054 dextranase contain less glucose (12 %-w/w)
and more small isomaltooligosaccharides (82 % - w/w) than those of the
dextran grown enzyme.

Isomaltose,

isomaltotriose

and

other

isomaltooligosaccharides are better acceptors for clinical dextran formation
than is glucose. An enzyme that produces isomalto series oligosaccharides
from dextran, is preferred for producing acceptors for clinical dextran
production. The broths of 30 % sucrose mixed culture fermentations contain
less than 1 % (w/v) glucose at the conclusion of the fermentation (Figure 27).
It is probable that this dextranase, as with the parental strain enzyme, is
composed of multi-isozymes, each with different properties (82).
Sucrose concentration is an important parameter in determining
dextran yields. Commercially, 15 % sucrose is used for dextran production.
The ability of an organism to grow in high sucrose is a function of the
osmotic stability of the organism. ATCC 74054 grew well in 15 % sucrose
compared to its parental strain (83). In the mixed culture system, a
discontinuous sucrose addition is used to maintain

the

sucrose

concentration at less than 10 % (w/v) at any given time.
Since the co-production of strains and two different enzymes are
required to make this mixed culture fermentation work, conditions for cell
growth, enzyme production, and enzyme reactions had to be optimized. The
goal of the process is the production, in high yields, of clinical or controlled
size dextrans. The fermentation was optimized for yield of clinical dextran. A
pH ranging between 5.1 and 5.4 is optimum for clinical dextran formation in
mixed culture. At pH 5.4, 72.7 % of theoretical yield of clinical dextran was
produced. At pH 5.2, 70.1 % was produced. The optimum temperature for
mixed culture fermentation was between 28 and 29 °C based on the clinical
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dextran yield. As the growth temperature increased from 26 to 32 °C
mesenteroides growth rate did not change, however, L. starkevi doubling
time decreased. The total dextran productivity followed

dextransucrase

activity. The highest dextransucrase activity was 0.32 IU/108 cells at 26 °C.
Interestingly, at 32 °C, there was still over 0.2 IU/108 cells. It was reported
that at temperatures above 30 °C, dextransucrase activity decreased sharply
(43, 85). Apparently the mixed culture system acts to stabilize this enzyme.
Willemot

et al.

reported that

thermally

inactivated

dextran-free

dextransucrase could be reactivated by the addition of exogenous dextran
(190). The presence of dextran in the mixed system may help stabilize this
enzyme (159).
The media were optimized for yeast extract concentrations. The
highest yield of clinical dextran was obtained with 0.9 % yeast extract, 70 %
of theoretical, in mixed culture fermentation. At the lower yeast extract
concentrations (0.3 %), dextransucrase and dextranase activities were
higher, however, clinical dextran production was lower. It appears that the
decrease was caused by excess dextranase which produced

high

concentrations of oligosaccharides. The oligosaccharides may act as
acceptors producing shorter dextran chains, to the point where the polymers
are too small to be useful. HPLC analysis confirmed the presence of high
concentrations of small oligosaccharides in the low yeast extract
fermentations (83). These small oligosaccharides do not readily alcohol
precipitate and may cause decreased yields. It appears that a balance
between dextranase and dextransucrase activity is essential for the success
of the mixed fermentation.
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Calcium has been reported to stimulate dextransucrase production
and is normally added commercial production schemes (138). No significant
increase in dextransucrase activity was seen in mixed fermentations with the
addition of calcium. Additionally, high dextransucrase activity, in the
absence of residual sucrose, is not necessary for clinical dextran formation.
Rather branched dextran formation is favored with the addition of calcium
when sucrose is absent (106, 159). Calcium and other divalent metal ions
have been reported to act as branching factors, though the reason is not
clear (186). Calcium was found to inhibit dextranase activity (Table 6, 93).
Because dextranase activity is required for the formation of small size
dextrans, calcium was not added to mixed culture fermentation.
Clinical dextran formation in the mixed culture system appears to be
the result of both dextranase action and acceptor reactions. It is logical that
the balance of sucrose to acceptor would be important. Dextranase addition
to bacterial pure culture fermentations resulted in high amounts of isomaltooligosaccharides only when there was no sucrose present (Figure 36). Few
oligosaccharides were found in the broth when sucrose was present. This is
an indication that the growth of the dextran was faster than the action of
dextranase. Fragments were immediately incorporated into new polymer
chains. A ratio of less than 4 to 1 sucrose to acceptor in mixed culture
resulted in high clinical dextran levels (83). Practically this means that the
sucrose concentration at any given period should be less than 4 times the
available acceptor concentration. Operationally less than 10 % (w/v) sucrose
was maintained at any given period. This minimized growth inhibition due to
high osmosity. Discontinuous sucrose addition was utilized. A single
sucrose addition (15 %) produces more total dextran, 83 % of theoretical
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(w/v), than a discontinuous addition, 74 %. However, the picture reverses
with regard to clinical dextran yields. Single sucrose addition produces 65.6
% of theoretical clinical dextran versus 68.8 % for discontinuous sucrose
addition. With 30 % sucrose the advantage of discontinuous addition
becomes apparent. The total dextran yield by single addition was 84.5 % of
theoretical and the yield by discontinuous addition was 87 % of theoretical.
The differences between clinical dextran yields were more apparent, 80.5 %
of theoretical for discontinuous addition and 61.7 % for single addition. The
higher productivity of discontinuous sucrose addition is reflected in the cell
number ratios of the mixed culture. The ratio of L. mesenteroides to L.
starkevi for discontinuous addition was 51 / 1 (15 % sucrose) and 22 /1 (30
% sucrose), and in case of single addition 306 /1 (15 % sucrose) and 100 /
1 (30 % sucrose). Balanced cell numbers means the appropriate ratios
between dextranase and dextransucrase are maintained for high yields of
clinical dextran. The sucrose consumption for cell growth did not increase
proportionally to sucrose concentration. At concentration higher than 15 %,
most of the additional sucrose was converted into dextran. Thus the specific
productivity (grams clinical dextran / 108 cells) increased as sucrose
concentrations were raised above 15 % (Figure 17). Dextransucrase
production, based on the cell numbers showed that residual activity at the
end of fermentation increased as sucrose concentration increased.
The inoculum ratio of L. mesenteroides to L. starkevi turned out not to
affect significantly either the final cell ratios or clinical dextran production as
long as the two cultures were co-inoculated over a broad range (1 /1 to 48 /
1 of L. mesenteroides to L. starkeyi). When the initial sucrose (3 %-w/v) was
consumed, cell numbers were generally balanced at 20 /1. The ratio of 4 /1
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was chosen as the optimum inoculum ratio. Under optimized condition, the
final cell number ratio of L. mesenteroides to L. starkevi ranged from 20 /1 to
40/1.
Several factors are known to affect dextran yields (5). They are
requirements for substrate dispersion, dextransucrase activity maintenance
by control of pH and temperature, viscosities control and by-product, i.e.,
fructose, levels. Fructose is a poor acceptor for dextran formation. When
fructose concentrations are high, glucose is transferred from sucrose to
fructose molecules with formation of a 1-5 linkage. The compound is
leucrose (a-D-Glu (1-5) p-D-Fru). Leucrose is not an acceptor for
dextransucrase. Mixed culture fermentation overcomes some of these
problems by maintaining a lower viscosities in the fermentation broth (less
than 50 times as viscous as pure culture broths). The concentrations of
isomaltose, isomaltotriose and other isomaltooligosaccharides are higher,
displacing fructose as an acceptor. These isomalto series oligosaccharides
are incorporated into dextran and show up as increased yield.
The lack of significant amounts of small oligosaccharides in the mixed
culture broth gave some insight into the mechanism of dextran production in
this system. The dextranase reaction produces small oligosaccharides
which are good acceptors for dextran formation. To confirm the incorporation
of small molecules into small dextran (by acceptor mechanisms), maltose
was added into bacterial pure culture fermentations.

After polymer

precipitation, using isopropanol, small size dextrans (not the high molecular
size dextran which is usually produced from L. mesenteroides
fermentations) were obtained. Acid partial hydrolysis produced panose (aD-Glc(1-6)-a-D-Glu(1-4)-D-Glu). This confirmed maltose incorporation into

142

small size dextrans. Mixed culture fermentations containing starch and
sucrose were also tested. L. starkevi ATCC 74054 produces an amylase as
well as dextranase (Table 3) on sucrose. This amylase produces similar
amounts of glucose, maltose, maltotriose and maltopentaose from starch
(soluble starch, pH 5.5, 83). A mixed fermentation containing starch and
sucrose produced primarily small molecular weight dextran (average M.W.
of 40,000). After the polymer precipitation, and acid or dextranase
hydrolysis, panose as well as other oligosaccharides were found in the
hydrolyzates. Thus starch hydrolyzates are incorporated into polymers
limiting the size of polymers. Presently, dextran hydrolysates, isomaltose
and/ or isomaltooligosaccharides, are incorporated into the dextran in mixed
culture in a similar manner, acting as acceptors for clinical dextran. This also
explains the absence of small isomaltooligosaccharides in mixed culture
fermentations.
Incubation of the partially purified dextranase with dextransucrase for
5 hours stimulated dextransucrase activity. It has been reported that the
displacement of a dextranosyl chain from the enzyme provides a nascent
enzyme that reacts more rapidly with sucrose (152). During mixed culture
fermentation it is possible that

both

dextranase

and

isomalto

oligosaccharides produced by dextranase, continuously regenerate the
active site. This appears as a stimulation of the enzyme activity. It has been
reported that dextransucrase activity decreases upon long term dextran
removal (190). However, since high amounts of dextran exist in the mixed
culture fermentation there was no dextransucrase inactivation upon the
addition of dextranase.
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Dextransucrase activity increased after exogenous dextran addition
during fermentation. LD (large size dextran, 1.15 x 106) stimulated
dextransucrase activity. The size of dextran produced was smaller than
native dextran. This is similar to an other report on the LMW dextran addition
effect to purified dextransucrase solutions (190). They found that low
molecular weight (LMW) dextrans obtained from acidic hydrolysis of native
dextrans acted as acceptors. Those LMW dextran have a higher acceptor
efficiency than maltose or glucose (113). It is probable that in the mixed
culture fermentation, when the concentration of oligosaccharides is high,
they act as acceptors. This gives rise to the next higher homolog, etc., until a
specific size is reached.
Depending on the sucrose concentrations varying proportions of high
molecular weight dextrans (HMW, 2 - 8 %-w/w) and low molecular weight
dextrans (LMW, 92 - 98 %-w/w) were found in the final product. Using both
dextranase and acid hydrolysis, it was detected that the HMW dextran was
not levan and only a portion contained non 1,6 linkages. The total non 1,6
linked portions were 5 - 6 % of the total dextrans. The dextran produced by
mixed culture fermentation has the same or similar structural composition to
the dextran produced by bacterial pure culture fermentation (187).
The new process for the production of clinical dextrans differs in
several steps from the traditional process. This process requires coinoculation and establishment of a co-culture. Discontinuous sucrose
addition is required. Because of higher sucrose concentrations (over 30 %),
the fermentation time is longer than traditional processes. When 30 %
sucrose is used to produce clinical dextran the time required is about 52
hours. For traditional fermentations, 24 hrs are required for 15 % sucrose.
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However, a further 24 hrs is needed for acid hydrolysis and subsequent
steps (Dr. Patel, personal communication). In addition, an extra 48 hr is
required to produce same amount of clinical dextran. One of the most
expensive steps in the traditional process, having the highest dextran loss, is
acid hydrolysis. The new process does not require acid hydrolysis. Because
acid hydrolysis is not required, deionization is not required. The clinical
dextran produced in mixed culture broth has a small polydispersity index.
The dextran size can be readily controlled simply by stopping the
fermentation at the desired size. The dextran produced by this new process
also needs less fractionation. This process produces small dextrans which
have lower viscosity, making cell removal easier.
There are many studies on clinical dextran production using purified
dextransucrase. Hydrolysis of sucrose provides the energy required for the
condensation of D-glucopyranosyl units. Thus dextran synthesis can be
carried out in vitro, using only purified enzyme and sucrose. A popular idea
for making clinical dextran with enzyme has been to use maltose as an
acceptor. Maltose can be used as an acceptor for the first reaction step. The
purified product obtained is used for the next reaction step. Dextrans of
molecular weights ranging from 1,000 to 100,000 have been made using
this method

with 80 % of theoretical yield. (148).

This process has

drawbacks. For separate enzyme production and enzyme purification steps,
more than a 5 fold larger amount of nutrients are required (4, 142, 184). The
a 1,4 linkage present in this dextran is readily degraded in humans (152).

Since about half of the clinical dextran produced contains maltose, this is a
structural drawback. In order to obtain suitable sized dextrans a multi-step
synthesis is required, i.e. a 4 step-process (148). The dextransucrase
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reaction theoretically converts 52 % of the sucrose to fructose. The fructose
concentration increases with every reaction step because it is not
consumed. When fructose concentration is high, it acts as an acceptor. The
end product of the reaction is leucrose which is not an acceptor.
Dextransucrase product sizes are controlled by controlling the ratio of
sucrose to maltose. To make controlled size dextran with dextransucrase the
ratio of sucrose and acceptor should be low (close to a 1: 1 ratio of sucrose
to maltose is required). Every reaction step in this multi-step process has to
be followed by polymer precipitation to prepare the acceptor for the next
stage. This is not a practical procedure for industrial scale fermentation.
An enzymatic hydrolysis method for clinical dextran has been
patented (129, 130). The advantage of this method is that the enzyme
solution can be allowed to act directly on a culture broth containing dextran.
This eliminates the preliminary precipitation of the dextran with alcohol. The
dextranase must be prepared separately and there is no way to recover the
dextranase for re-utilization. The product is generally of very small size
unless the dextranase is properly inactivating or being purified. This process
has not achieved commercialization.
Commercial fermentation media consists of 5 g / L yeast extract, 5 g /
L KH2PO4, an 15 % (w/v) sucrose, and trace amounts of peptone (Dr. Patel,
personal communication). Mixed culture system requires yeast extract (8.5 g
/ L) and same amount of KH2PO4 (5 g / L), 30 % sucrose, and no peptone.
The medium cost $ 3.1 per Kg of clinical dextran produced for traditional
methods. With its higher yields and productivities, the media cost for mixed
fermentation $ 2.1 per Kg of clinical dextran. The dextran market is several
billion Kg a year world wide. The dextran price depends on the quality.
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Crude dextran sells for about $ 3 / Kg whereas clinical dextran sells for over
$ 50 / Kg (D,r. Patel, Personal communication). Not including production
simplification, this new process has the advantage in lower production cost.
Dextran precipitation by alcohol concentrations is related to dextran
size. The precipitation efficiency of alcohol for clinical dextran is methanol <
ethanol < isopropanol. A commercial neutral hydrolyzate of 5 % dextran
contains approximately 2 % sodium chloride (199). When dextran is
precipitated from the acid hydrolyzate, practically all of the sodium chloride
remains behind. The new process does not include acid hydrolysis or
neutralization step, thus the fermentation broth does not contain sodium
chloride. Dextran recovery by precipitation increased upon the addition of
some salts (Ms. Sarkar, D., personal communication, Audubon Sugar Inst.,
LSU). KH2PO4 and/or MgS04 improved the recovery more than NaCI. The
optimum salt concentrations depended on the dextran concentration (and
size). Ions are known to affect water activity by reducing the water available
for dextran hydration. Ion addition also increases specific gravity (199). The
addition of salts helps to diminish solvent usage. The modest product value
of dextran requires efficient recovery and solvent re-uses, as well as good
solvent removal from food and pharmaceutical grade products. The addition
of 0.6 % salts (KH2PO4 or MgS04) to 5 % dextran solution showed "salt in"
effect on isopropanol precipitation (83). It has been reported that high salt
concentrations (about 15 %-w/v) increase the ionic strength of dextran
solutions and inhibit the precipitation of dextran (198). Additional studies for
optimum salts' concentrations for various dextran level is needed. Proteins
(or residual dextranase) in dextran can be removed by activated charcoal.
Since commercial practice uses activated charcoal to remove color from
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dextran solutions, the dextranase does not require an additional process for
removal.
Using ruthenium red addition in conjunction with osmium tetroxide, it
was possible to examine dextran produced in mixed and bacterial pure
culture fermentations. The morphologies of high molecular weight and low
molecular weight dextrans were different. High molecular weight dextran
prepared from bacterial pure culture fermentations showed a net like
structure. However, mixed culture fermentation polymers showed up as
smooth surfaces, although the bacterial cells were surrounded by net like
materials. Since dextran is a neutral polysaccharide, the interaction of the
dextran with ruthenium red is interesting. It has been suggested that the role
of ruthenium red is the formation of an electron dense deposit with OSO4 at
the location of the polysaccharide (107). The ruthenium red must then be
making insoluble dextran polymer which reacts with OSO4. The formation of
ruthenium red complex may occur via free hydroxyl groups. The intense
electron density of dextran is probably due to the formation of an osmium
black complex with the dextran. The net like appearance of high molecular
weight materials vs the smooth appearance of low molecular weight
materials may become a useful diagnostic tool for polymer size and should
be investigated further.
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